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Articular cartilage injuries require 
surgical intervention in order to re-
generate repair tissue. In this thesis, 
tissue engineering of cartilage was 
studied using a novel biomaterial of 
recombinant human type II collagen 
(rhCII) as a scaffold for chondrocytes. 
This work confirmed the feasibility of 
rhCII to be used for cartilage tissue 
engineering. When osteochondral de-
fects were repaired with rhCII, slight 
improvement was detected in the 
filling of the lesions and in mechani-
cal properties of the repair tissue in 
comparison to spontaneous healing. 
These results also emphasize the 
complex nature of cartilage repair and 
the importance for further studies.
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ABSTRACT 
 
Adult cartilage has a limited intrinsic capacity to regenerate and heal 
after injury. Therefore, a range of repair techniques have been adopted in 
an attempt to restore function and prevent further degeneration and 
development of osteoarthritis. Tissue engineering (TE) of cartilage using 
biodegradable material as a scaffold for chondrocytes could help the 
restoration of functional tissue. In this thesis a novel biomaterial, 
recombinant human type II collagen (rhCII), was tested as a scaffold for 
chondrocytes. The rhCII was proven to be a safe material for 
chondrocytes, and it allowed cell growth and production of cartilage 
ECM constituents, type II collagen and proteoglycans (PGs). When rhCII 
was used as a scaffold to repair osteochondral defects in a rabbit model, 
the repair tissue contained typical articular cartilage ECM and the use of 
rhCII helped to achieve better filling of the cartilage defect. The rhCII-
assisted repair tissue integrated well to the subchondral bone and the 
tissue showed mechanical durability especially in the deeper zones. 
However, the repair quality was not much improved when compared to 
the spontaneous healing process. In addition, the superficial layer of 
repair tissue showed fibrillation and type I collagen production. 
Furthermore, the integration into the adjacent cartilage was not complete 
in either rhCII assisted or the spontaneous repair tissue. Therefore, before 
rhCII can be used in human patients, further studies concerning 
enhancing the integration, and preventing surface fibrillation of the 
repair tissue, are needed. 
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TIIVISTELMÄ 
 
Nivelruston vaurioituessa sen kyky korjaantua itsestään on lähes 
olematon. Biohajoavien tukimateriaalien ja solujen käyttö nivelruston 
kudosteknologiassa voi auttaa rustokudoksen korjauksessa ja 
toiminnallisuuden palauttamisessa. Tämän väitöskirjan tavoitteena oli 
testata uutta biomateriaalia: ihmisen rekombinantti tyypin II kollageenia 
(rhCII) rustosoluille tukimateriaaliksi. Tulokset osoittivat, että rhCII-
materiaali oli rustosoluille turvallinen kasvuympäristö, ja sen käyttö 
solujen tukimateriaalina mahdollisti solujen kasvun ja ravinteiden 
saannin. RhCII tukimateriaalissa viljellyt rustosolut tuottivat nivelruston 
soluväliaineelle tyypillisiä aineosia: tyypin II kollageenia ja 
proteoglykaaneja. Kun rhCII materiaalia käytettiin rustovaurioiden 
korjaamiseen eläinmallissa, huomattiin että korjauskudoksessa esiintyi 
rustolle tyypillistä kudosta, korjauskudos kiinnittyi hyvin rustonalaiseen 
luuhun ja korjauskudoksen mekaaninen kestävyys oli jonkin verran 
parempi kuin spontaanissa korjauskudoksessa. Lisäksi rhCII paransi 
rustovaurioiden täyttöastetta. Verrattaessa rhCII:n avulla saatua 
korjauskudosta spontaaniin korjaustulokseen, ei merkittäviä eroja 
kuitenkaan havaittu. Lisäksi sekä rhCII ja spontaani korjauskudos olivat 
pintakerrokseltaan säikeisiä ja sisälsivät rustolle epätyypillistä tyypin I 
kollageenia. Myös kiinnittyminen viereiseen, terveeseen rustokudokseen 
oli paikoitellen puutteellinen. Jatkossa tulisi tutkia kiinnittymistä 
parantavien aineiden käyttämistä sekä mahdollisesti pintakerroksen 
peittämistä ennen mahdollisia potilassovelluksia. 
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1 Introduction  
Articular cartilage exists as a thin layer of avascular tissue covering the 
ends of the bones in synovial joints. It is composed of a relatively low 
number of cartilage resident cells called chondrocytes. These cells 
produce the extracellular matrix (ECM) that is specific to this tissue, 
which mainly contains type II collagen and proteoglycans (PGs) 
(Buckwalter 1998b). Normally functioning cartilage is required for the 
flexible movement of joints. However, if adult cartilage is damaged, it 
has a limited intrinsic capacity to regenerate and heal (Newman 1998). 
Cartilage injuries cause pain and immobility and can lower the ability of 
the joint to function and furthermore debilitate the quality of life. If left 
untreated, cartilage defects can predispose the injured person to the 
development of a much more severe condition, osteoarthritis (OA) 
(Brown 2006, Messner 1996). 
However, since spontaneous repair of articular cartilage is poor, 
several methods have been developed in order to improve it’s healing. 
Conventional methods to repair cartilage defects include different 
surgical procedures; such as drilling and shaving, as well as 
microfracturing (Hunziker 2002). These methods are based on alleviating 
pain with improved joint mobility, and on findings that bone marrow 
stimulation can promote growth of new tissue. However, the outcome in 
these techniques differs amongst patients, and many unsatisfactory 
results have been reported.  
Due to the development of cell culturing and biomedical materials 
engineering, a new approach to regenerative medicine has emerged. 
Tissue engineering (TE) of cartilage seeks to aid the regeneration or 
repair of articular cartilage in the defective areas by using transplanted 
cells and biocompatible materials in an effort to grow new functional 
tissue. At this moment TE is considered a promising solution to repair 
cartilage defects and to produce sustainable regenerative tissue. A wide 
variety of materials have been tested as scaffolds for chondrocytes, but 
perhaps the most promising ones are natural materials that could offer a 
surrounding that mimic the innate environment of the cells. One such 
molecule is type II collagen. 
Type II collagen has been tested as a scaffold for chondrocytes with 
promising results in rabbits and dogs for articular cartilage TE as 
previously reported (Funayama 2008, Lee 2003, Nehrer 1998). The 
collagens that are currently used are of animal origin, and therefore raise 
questions about safety (Lynn 2004). As an alternative source for collagen, 
2 
 
 
a technique to manufacture human recombinant collagen in yeast 
cultivations (Pichia pastoris), has been developed (Myllyharju 2000). This 
manufacture process has been shown to produce hydroxylated triple 
helical collagen that builds up a structure with a thermal stability similar 
to native collagen when coexpressed with recombinant prolyl 
hydroxylase (Baez 2005). 
The aim of this thesis was to investigate the properties of recombinant 
human type II collagen (rhCII) as a novel biomaterial to be used as a 
scaffold for chondrocytes in articular cartilage TE. This rhCII material 
was first tested as a coating material for cellulose scaffolds, and was 
demonstrated to improve the chondrocyte attachment in these scaffolds. 
The feasibility of the rhCII material was then investigated as a gel-like 
formula, first in cell culture conditions in vitro, and then in animal models 
in vivo. Various methods to analyze the cellular properties and matrix 
production of chondrocytes cultivated in rhCII, and furthermore the 
tissue structure and mechanical properties of the TE rhCII constructs, 
were applied. The results obtained in this thesis provide important 
information about cartilage repair and the limitations of the current 
techniques. 
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2 Review of the literature 
2.1 ARTICULAR CARTILAGE 
Articular cartilage, also called hyaline cartilage, is an avascular form of 
connective tissue originating from mesenchyme. It is located in synovial 
joints, forming a thin cartilaginous layer covering the articulating 
surfaces of the bones (Figure 1). The synovial joints are closed systems, 
encapsulated by a synovial membrane. The cells in the synovial 
membrane excrete synovial fluid, which together with the articular 
cartilage allows nearly frictionless movement of the enclosed joints. 
Figure 1. A schematic representation of the structure of a human knee joint, 
and a larger magnification of the structure of the articular cartilage. The 
articular cartilage (light blue in figure) is located on the surfaces of the 
articulating bones. The joint capsule encloses the joint cavity. The structure 
of articular cartilage consists of chondrocytes and an extracellular matrix: 
type II collagen and proteoglycans organized in a depth-dependent manner 
(Newman 1998). The collagen fibrils are arranged as an arched structure, 
and the arch-like organization is shown in the picture as dotted white lines.  
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The role of articular cartilage as a load-bearing tissue has a major impact 
on the structure and function of this tissue. Articular cartilage is 
composed of a relatively small fraction of cells, called chondrocytes, 
within a large amount of extracellular matrix (ECM, Figure 1). The main 
components of the solid ECM are type II collagen and proteoglycans 
(PGs). However, the greatest constituent of the extracellular tissue is 
water.  
2.1.1 Chondrocytes 
In addition to the recently discovered progenitor cells (Dowthwaite 
2004), the predominant cell type found in normal articular cartilage is the 
chondrocyte. They are rather low in their numbers, and occupy only 1-
10% of the tissue volume (Stockwell 1967). Although adult chondrocytes 
do not divide after maturation in normal articular cartilage (Aigner 2001), 
they interact actively with the ECM throughout their life. The interaction 
is mediated via different ECM-binding, cell surface receptors, such as 
integrins (Salter 1992) and CD44 (Aguiar 1999) that connect the cells to 
ECM (Figure 2). Interactions and adhesions to the ECM are crucial for cell 
survival. Integrin-mediated signals block apoptosis and stimulate cell 
cycle progression amongst other things (Hirsch 1997, Knudson 2002). 
Body movements change the loading in the cartilage, and this further 
generates deformation and adjustment in the ECM molecules. These 
mechanical movements of the ECM molecules activate the ECM-binding 
receptors (Fitzgerald 2004). The activation of the ECM-binding receptors 
generates intracellular signaling pathways, which lead to alterations in 
the gene expression and eventually production of desired proteins 
(Hynes 2002) or changes in the cell shape (Knudson 2002). The 
mechanism of mechanotransduction is still not fully understood 
(Knudson 2002). Changes in other mechanical, electrical or 
physiochemical factors also affect the metabolism and function of 
chondrocytes (Urban 1994).  
In addition to mechanotransduction, several biologically active 
molecules have a profound influence on the function of the chondrocytes. 
These include growth hormones, such as transforming growth factors 
(TGF-β), bone morphogenetic proteins (BMPs) (Hanada 2001) and 
insulin-like growth factor-1 (IGF-1) (Smith 2000), as well as cytokines 
including interleukins (IL-1) and tumour necrosis factor (TNF-α) 
(Saklatvala 1986). Combined with the information from the ECM 
receptors, these factors either induce or suppress the production of ECM 
molecules or ECM degrading enzymes. This constant monitoring and 
adaptation leads to modification of the ECM when needed. However, in 
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normal mature cartilage, remodeling is a constant but minimal process, 
and it is during the growth or disorders such as osteoarthritis, when the 
production and degradation of the ECM are most active (Goldring 2006). 
Due to the lack of blood vessels in cartilage, nutrients and oxygen, 
originating from the synovium and mediated via the synovial and 
extracellular fluids, reach the cells by diffusion (O'Hara 1990). This leads 
to the fact that the oxygen levels of cartilage are rather low, especially in 
the deep regions (Treuhaft 1971). This means that these cells derive most 
of their energy by anaerobic glycolysis (Gibson 2008). The rate of 
chondrocyte activity and metabolism is also related to age (Martin 2002). 
Once an individual reaches skeletal maturity, the cellular processes and 
matrix production slow down. For a long time, it was not clear whether 
the cells in mature animals can divide or not (Mankin 1982). However, 
since the development of cell culturing techniques, it has been confirmed 
that adult animal derived chondrocytes can also divide, if the cells are 
isolated and cultivated in cell culture conditions. 
 It was long presumed that the chondrocytes are the only cell type that 
populates the cartilage tissue, but recent investigations show, that a 
group of stem/progenitor cells are found in the cartilage tissue, especially 
in the superficial layer (Dowthwaite 2004, Hattori 2007). The exact 
function and purpose of these cells still remains under speculation, but 
the surface cells are reported to actively express many growth factors, 
exhibit plasticity in differentiation, and they may have an important role 
in the appositional growth of the articular cartilage (Dowthwaite 2004). 
2.1.2 Cartilage collagens 
Collagens are essential for the structural integrity and stiffness of ECM, 
and they are the major molecular component of the articular cartilage, 
amounting 50-80% of the dry weight (Mow 1992). The most abundant 
collagen in the articular cartilage is fibrillar type II collagen (90-95% of 
collagens). However other fibrillar or non-fibrillar collagens can be 
found, (e.g., types III, VI, IX, X and XI) in smaller amounts (Eyre 2002). 
Type II collagen possesses a rod-like structure that is composed of 
three identical intertwined polypeptide chains, which are called collagen 
α1(II)-chains. These α-chains are comprised of amino acids in repeating 
sequences of glysine-X-Y, where X is very frequently proline and Y is 4-
hydoxyproline. The biosynthesis of collagen requires many modification 
phases, both inside and outside of the cell (Figure 3). In the beginning of 
the process the specific gene, in the case of type II collagen, COL2A1, is 
transcribed and processed into messenger RNA (mRNA). Then the 
translation of the mRNA and production of the α-polypeptide chains 
takes place in membrane-bound ribosomes. Post translational 
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modification of the freshly synthetized chains starts right after 
translation. (Prockop 1995). 
 
Figure 2. Chondrocyte and ECM molecules. The cell surface receptors, such 
as CD44 and integrins, are essential for cell survival and maintenance. CD44 
binds to hyaluronan, and integrin receptors to collagens. Several aggrecan 
PGs, often more than 50, are connected to a hyaluronan core, forming large 
PG aggregates. Type II collagens exist in large collagen fibrils. Also several 
other PGs, and non-collagenous proteins, exist in the ECM but are not shown 
in the picture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The collagen production by chondrocytes and self-assembly of  
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collagen fibrils. First the synthetized α-chains form the triple-helix 
procollagen, which is then secreted and modified outside the cell. After 
proteolytic cleavage of propeptide domains the collagen (tropocollagen) 
molecules assembly and form a collagen fibril, a structure that is stabilized 
with cross-linking, hydrogen bonds and water bridges. Figure is inspired by 
the review by Kadler et al (Kadler 1996). 
 
The modification of the procollagen α-chains in endoplasmic reticulum 
allows them to form a folded triple helix structure in which three α-
chains are united. At this point, the structure undergoes further post-
translational modifications before it is secreted outside the cell via 
secretory vesicles. The secreted procollagen molecules contain flanking 
non-collagenous propeptide domains, which are proteolytically cleaved 
by specific proteinases during the extracellular maturation process, 
leaving short N- and C-terminal telopeptides on both ends of the 
molecule. (Prockop 1995). The remaining telopeptide structures serve as a 
linking site for neighbouring collagen molecules to connect with each 
other (Miyahara 1982). When the triple-helical collagen molecules are 
connected with each other as a bundle, a large collagen fibril is formed. 
This process takes place spontaneously at physiological pH due to the 
hydrophobic properties and negative charges in certain areas of the 
chains. The formation of hydrogen bonds and water bridges between the 
chains further strengthens this structure (Brodsky 2005), together with 
cross-links that are formed between lysine redidues that are catalyzed by 
lysyl oxidases (Prockop 1995). Type II collagens are also cross-linked with 
other collagens, mainly type IX and XI, which help to stabilize the 
network structure (Eyre 2002). 
The structure of collagen fibrils varies in the different areas of the 
cartilage ECM. Near the cells in the pericellular region the fibrils are 
thinner, around 20 nm in diameter. Elsewhere, in the ECM, the fibrils are 
thicker, approximately 60-90 nm in diameter (Holmes 2006, Minns 1977). 
As previously mentioned, type II collagen molecules interact with 
another fibrillar collagen (type XI) and with a fibril-associated collagen 
(type IX) in normal cartilage. The amount of type IX and XI collagens in 
proportion to type II collagen and is at it’s highest in the thinnest, 
pericellular fibrils (Eyre 2002). These collagen interactions are believed to 
play a role in regulation of cartilage collagen fibril diameter and in 
stabilization of the fibrillar network (Eyre 2002, Kadler 1996). Besides 
that, the PGs in the ECM interact with the type II collagen and play a role 
in the interfibrillar connections (Scott 1988, Vynios 2001). Collagen 
(hetero)fibrils are arranged in the ECM as a network (Figure 1), and the 
orientation of the fibrils changes in relation to the depth and location of 
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the tissue (Buckwalter 1998b). The network is arranged when several 
collagen fibrils assembly in paraller direction and form large bundles. 
The process of fibril assembly and organization is still poorly understood 
at the moment. 
Type II collagen fibrils are stable structures and are resistant to most 
proteinases. The type II collagen produced during growth can exist for a 
very long time, lasting even decades. Thus, in normal adult cartilage, the 
synthesis of new type II collagen is minimal (Aigner 1992, Gebhard 2003). 
Collagen degradation can be achieved by specific proteolytic enzymes, 
called collagenases, which are produced by chondrocytes. Collagenases 
cleave the collagen molecules into shorter fragments. The specific 
collagenase for type II collagen is collagenase-3 (also called MMP13), a 
member of the matrix metalloproteinase (MMP) family. Additionally, 
MMP-1 and MMP-8 have been shown to degrade type II collagen. 
(Dahlberg 2000). In normal conditions, the occurrence of MMP13 in 
cartilage is low, but during dynamic processes such as growth (Inada 
2004) and disease, for example, osteoarthritis (Dahlberg 2000, Reboul 
1996), the production of MMP13 is elevated, and tissue degradation is 
accelerated. The degradation of collagens is further balanced by secretion 
of tissue inhibitors of MMPs (TIMPs) that are upregulated by growth 
factors and block MMP activity (Cawston 1999).  
2.1.3 Proteoglycans and other matrix molecules 
Inside the collagenous network, there is a vast amount of other non-
collagenous proteins, mostly PGs. These have an important role in the 
function of articular cartilage, especially in providing the osmotic 
resistance to the tissue under the loading stress. Studies show that PGs 
compose of around 30% of the dry weight of the articular cartilage 
(Buckwalter 1998b). They are molecules that contain a core protein, onto 
which one or more carbohydrate side chains of glycosaminoglycans 
(GAGs) are attached. The GAGs are defined as long non-branched 
polysaccharide chains that contain successive disaccharide units 
consisting of an amino sugar (N-acetyl glucosamine or N-acetyl 
galactosamine) in one position, and uronic acid or galactose in the other. 
In cartilage, the GAGs are mainly chondroitin sulphate, keratan sulphate, 
dermatan sulphate, and hyaluronan (HA). HA is the only GAG, which is 
not bound to a core protein (Lash 1983).  
The major PG in articular cartilage is a large aggregating molecule 
called aggrecan. Other aggregating molecules are versican and link 
protein. There are several other PGs in the cartilage ECM, some of the 
most studied include decorin, biglycan, lumican and fibromodulin. Each 
PG is identified by the amount and quality of GAGs attached to the core 
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protein, for example, aggrecan has a large amount of chondroitin 
sulphate and keratan sulphate side chains. Aggrecan exists in the ECM as 
PG aggregates; each aggregate is composed of a HA central filament with 
up to 100 aggrecan molecules attached to it (Figure 2). This structure is 
further stabilized by a link protein, a protein that has the capacity to bind 
both aggrecan and HA. (Roughley 2006). 
PG biosynthesis involves the synthesis of the core protein and post-
translational addition of GAG chains in the Golgi complex (Hascall 1988). 
The newly completed PGs are then secreted into extracellular space 
where possible extracellular maturation, interaction with the ECM and 
aggregation with HA takes place. The synthesis and catabolism of 
aggrecan by chondrocytes is responsive to several soluble mediators, as 
well as to mechanical loading (Vertel 2000). Unlike collagens, which are 
fairly stable in their structure, aggrecans and some other PGs are 
constantly synthesized and degraded in the tissue. The enzymatic 
degradation of aggrecan is processed mainly through matrix 
metalloproteinases (MMPs) and aggrecanases (Sztrolovics 1997). 
There are also other proteins that are neither collagens nor PGs, in the 
cartilage ECM. Perhaps the best known is the cartilage oligomeric protein 
(COMP).  
In their normal state, the GAGs are negatively charged and, therefore, 
they attract cations near them. The increased osmolarity (concentration of 
solutes) of the tissue draws water inside the cartilage ECM and creates 
swelling pressure in the tissue. In turn, the osmotic swelling of the tissue 
is prohibited by the collagen fibrils. These two counter-balancing forces, 
the osmotic swelling and the elastic stretching of the collagen fibrils, 
determine, and have major impact on, the function and properties of 
articular cartilage as a tissue (Mow 1999).  
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2.1.4 Structure and organization 
Articular cartilage exists as a relatively thin tissue layer. The thickness of 
this tissue varies regionally and depends on the magnitudes of loads in 
different regions and joints. For instance, in a heavy weight-bearing joint, 
such as the knee, the thickness can vary between 1-3 mm in the human 
femur and tibia and up to 5 mm in the patella (Shepherd 1999). The 
chondrocytes and ECM molecules are distributed throughout the 
cartilage in a depth- and site-dependent manner (Figure 1). Everywhere 
in between the solid matrix molecules there is a large amount of water 
that can constitute as much as 80% of the wet weight of articular 
cartilage. Based on histological analysis, the articular cartilage has been 
divided into four different zones: superficial, transitional (middle), deep 
(radial), and calcified cartilage (Figure 1). The tissue is not homogenous; 
chondrocytes and ECM molecules differ in their morphology and density 
in different zones. (Newman 1998). 
The superficial zone is further divided into two layers: a topmost 
acellular and nonfibrous, i.e. amorphous layer (Buckwalter 1998b, 
Jurvelin 1996), and a deeper layer of flattened chondrocytes (or 
progenitor cells) with a dense matrix of collagen fibrils arranged parallel 
to the surface (Buckwalter 1998b). The supercifial zone presumably has 
great importance to the compressive behavior and function of articular 
cartilage. It has a major influence on the lubrication mechanism operating 
between the joint surfaces, and acts as an outer barrier for the cartilage 
tissue. The collagen fibrils there are organized in parallel fashion to offer 
a greater strength and tensile stiffness to this upper zone of cartilage. In 
this zone, the chondrocytes/progenitor cells synthesize less ECM 
molecules than in other zones, and the water content is high. (Buckwalter 
1998b). 
In the transitional (middle) zone the chondrocytes are rounded or 
spherical in their shape, and they are more active and synthesize more 
ECM with thicker collagen fibrils and a higher PG content. The deep zone 
is characterised by spheroidal shaped chondrocytes aligned into columns 
perpendicular (radial) to the joint surface. This zone has the highest 
amounts of PGs and the lowest concentration of water. Also in this layer, 
the collagen fibrils are organized in a radial network. In the bottom of the 
deep zone lays a histologically detectable basophilic thin layer called the 
“tidemark”. Under the tidemark is a relatively thin zone of calcified 
cartilage. The cells and matrix there form the boundary between the 
upper uncalcified cartilage and the subchondral bone. (Buckwalter 1999). 
In addition to the four horizontal matrix subdivisions mentioned 
above, cartilage tissue ECM can also be identified in its relation to the 
chondrocytes, these regions are: the pericellular region (closest to the 
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cells), the territorial region (surrounding pericellular region), and the 
interterritorial region (rest of the tissue). Around the cells, in the 
pericellular region, there are no thick collagen fibrils present, but a large 
amount of PGs, hyaluronan and thin fibrils of type VI collagen. The 
pericellular area is surrounded by pericellular capsule, forming a 
structural and functional unit called the chondron. The chondron area is 
the active environment of the cell, where the interaction with the matrix 
happens. (Poole 1997). In the pericellular layer the composition and 
properties of matrix differ from the surrounding ECM, and therefore it 
has different elastic properties and a significant role in altering the 
principal stress and strain magnitudes within the chondrocytes (Guilak 
2000).  
2.1.5 Function and biomechanical properties  
The location of articular cartilage between the bones in diarthrodial 
(synovial) joints highly determines the purpose of the tissue, that is, to 
withstand and transmit mechanical forces emerging from motions. In 
order to fulfill this task, the articular cartilage must perform functions 
related to lubrication and wear-resistance. The lubrication and 
minimization of friction is mediated by two main mechanisms. The cells 
of the synovium secrete synovial fluid into the joint cavity, and this fluid 
together with pressurized tissue fluid results in the formation of fluid 
film between the joint surfaces during high loads. A small glycoprotein 
called lubricin, (also known as superficial zone protein, SZP, or 
proteoglycan 4, PRG4), is secreted by synovial cells and chondrocytes, 
and plays an important role in the lubrication. It is a component of the 
synovial fluid and also exists attached to cartilage surfaces. There it acts 
as a lubricant, protects the surface chondrocytes and prevents an 
abnormal growth of the cells (Rhee 2005). At low loads, the load is 
supported by surface-to-surface contact, and the lubrication is due to the 
lubricant surface molecules (Schmidt 2007). All of the tissue components, 
the chondrocytes and the ECM, including the water, collagens and PGs, 
have a special, interconnected role in the weight-bearing capacity of the 
tissue.  
The collagen fibrils arranged in an arch-like network form the 
structural backbone and scaffold of the articular cartilage (Chen 1998). 
The collagen fibrils have good tensile strength. They enable resistance to 
the deformation of the tissue, which is created by the external mechanical 
load and internal osmotic pressure. The PGs that are mechanically or 
chemically bound to collagen and immobilized inside the cartilage ECM 
contribute to the formation of the osmotic pressure by attracting water 
molecules inside the tissue. But unlike the stabilized, large PGs, the water 
12 
 
 
can flow freely through the tissue and this has a major effect on the 
mechanical function of articular cartilage.  
Charasteristics of the water flow and the mechanical properties of 
cartilage differ depending on the rate of the loading. Under rapid 
loading, there is no time for the water to move, therefore, the 
arrangement of collagen fibrils withstands the load and cartilage behaves 
as an incompressible elastic solid (Suh 1995). However, during a constant 
and continued load, the water starts to flow and relocate inside the tissue, 
and out of the cartilage, resulting in compression. Initially, the water flow 
is relatively rapid under loading, but as a function of time, it slows down 
and eventually mechanical equilibrium is achieved when the deformation 
ends. Since the GAGs are responsible for attracting water into cartilage, 
the GAG content and properties affect the capacity to restrict tissue fluid 
flow and to resist tissue deformation, especially in static compression. If 
the loading of the cartilage tissue is too high, exceeding the bearing 
capacity of the tissue, it can cause tissue damage, such as collagen fibril 
breakdown, loss of PGs and chondrocyte apoptosis or necrosis. 
Furthermore, the damaged tissue becomes even more vulnerable to 
mechanical loading, because of the increased permeability and decreased 
ability to adjust to compression. In that regard, the measurement of 
cartilage mechanical properties can be used to evaluate the quality of the 
tissue. 
The mechanical properties of cartilage can be studied by applying 
loading to cartilage and measuring its deformation. Usually cartilage is 
studied using unconfined compression, confined compression or 
indentation measurements. For all of these loading geometries three 
different loading schemes can be used for measurements: stress-
relaxation, creep test or dynamic test. For the computation of the results, 
the structure of the cartilage has to be simplified and the results of the 
experiments need to be analysed using numerical or analytical models. 
One of the classical models is the biphasic model, where the solid 
components of cartilage are put together to constitute the solid phase of 
the tissue, and the interstitial fluid forms the fluid phase (Myers 1983). 
Since then, more sophisticated models have been developed, which also 
take into account the organization of the ECM and fibril properties 
(Korhonen 2003). 
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2.2 CARTILAGE DEVELOPMENT AND GROWTH 
The maintenance, turnover and development of articular cartilage are 
highly regulated and are influenced by mechanical forces. These forces, 
such as pressure and shear, influence the expression of gene’s that 
regulate differentiation, growth and matrix production of the 
chondrocytes. The development of cartilage can be regarded as having 
two parts; a prenatal phase of differentiation, expansion and rapid 
growth, and a postnatal period of tissue maturation, during which major 
modifications take place. The mechanisms and circumstances during 
normal development have been widely investigated, in order to gain a 
deeper sight into cartilage repair or regeneration. Information about 
normal development should also be taken under consideration when 
cartilage tissue engineering methods are designed. 
2.2.1 Prenatal development 
During embryogenesis, the cells from the early mesenchyme undergo 
several changes that lead to their differentiation into chondrocytes, a 
process called chondrogenesis. Once the chondrocytes are differentiated, 
they start to produce their characteristic ECM: type II collagen and PGs. 
(Goldring 2006). This complex process of growth and progression is 
precisely arranged through several growth factors and other signaling 
molecules, such as BMPs, that guide the cells (Barna 2007). Early 
chondrocytes start to produce the outline of the skeletal system by 
producing more ECM and dividing rapidly. At this point the 
chondrocytes are building up a precursor tissue, which serves as a 
transient model for the long bones of the body. This hyalinous model 
begins to rapidly grow and elongate through cell divisions and active 
ECM production. (Ferguson 1998). Several mediators work together and 
cause the central cells to undergo further differentiation. Many of these 
growth factors and transcription factors are mechanosensitive, which 
means their expression is influenced by the local mechanical 
environment (Carter 2004). In addition, oxygen levels affect the fate of the 
differentiating cells. Eventually, the centrally located chondrocytes begin 
to undergo hypertrophy and produce type X collagen. (St-Jacques 1999). 
The chondrocytes on the periphery continue their rapid growth, but at 
the same time the hypertrophic cartilage is invaded by blood vessels and 
bone forming cells, osteoblasts, that start to create the mineralized bone 
tissue. This process of bone formation, called endochondral ossification, 
starts in the central regions. As the process of bone formation progresses, 
the cartilaginous precursor model is then almost totally replaced by bone. 
The only cartilaginous remnants are the growth plate, also known as the 
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physis, which is left inside the bony structure in proximity to each of the 
bone ends, and the articular cartilage, that now covers the ends of the 
bones (Goldring 2006). 
Compared to the absence of growth in the adult cartilage, this rapid 
progress of development is striking, and it has been broadly investigated 
(for reviews, see (DeLise 2000, Goldring 2006)). During fetal 
development, the chondrocytes produce ECM that is nonhomogenous 
and has randomly distributed collagen fibrils (Hunziker 2007). Initially, 
the collagen fibrils are also few in number, as well as thin in diameter 
(Keene 1995). In the fetal articular cartilage, the water content is higher, 
cellularity much denser, collagen content lower, and the tissue much 
softer than in the adult articular cartilage (Williamson 2001). 
   
2.2.2 Post natal development and maturation 
After birth, the transient cartilage that is still present in the growth plates 
continues to grow and, at the same time, is gradually replaced by the 
bone. This process enables the elongation of the long bones after birth, 
and it continues until skeletal maturity is reached. Also the articular 
cartilage covering the ends of the bones undergoes several changes, 
during which the originally soft and homogenous tissue matures into 
durable cartilage with zonal organization. This postnatal development 
has been suggested to take place in close relation to the bone formation 
and in fact, this cartilage layer may act as a surface growth plate for the 
underlying subchondral bone (Hunziker 2007). Nevertheless, the 
development of bone and cartilage occurs in close proximity and in 
relation to each other. When skeletal maturity is reached, the individual’s 
longitudinal growth ceases, which happens at the same time as the 
maturation of articular cartilage. It is noteworthy that cartilage in 
different joints of the body appears to be rather similar during fetal 
development, and it is after the birth that regional and joint-dependent 
differences arise, in response to the differences in loading stress 
(Williamson 2001). 
During growth, both the thickness and water content of the articular 
cartilage decrease (Julkunen 2009, Rieppo 2009, Williamson 2003), while 
the collagen content rapidly increases (Julkunen 2009, Rieppo 2009). 
These changes are a result from gradual adaptation to the joint 
movements and weight-bearing. At least in some species, the 
chondrocytes have been detected to proliferate after birth, especially in 
the superficial layers (Archer 1994).  However, in general, proliferation of 
the chondrocytes ceases after birth and the amount of cells in relation to 
the ECM is decreased due to the massive production of the latter 
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(Williamson 2001). Gradually, the chondrocytes also begin to form 
groups and columnar structures, as the thickening ECM encloses the 
chondrocytes (Clark 1997). 
The collagen fibrils and network have been shown to undergo 
significant changes during maturation. Step by step, the collagen network 
develops from the homogenous and parallel-to-surface orientated 
structure into the mature arch-like orientation (Julkunen 2010, Rieppo 
2009). This transformation of the finely organized network of collagen 
fibrils contributes to the formation of the zones of the cartilage, and it is 
essential for the proper function of articular cartilage (Julkunen 2010). 
Previously it was assumed that this reorganization is achieved by 
internal remodeling, but some speculation exist whether the maturation 
of collagen fibrils is instead a progression of tissue resorption and 
neoformation in a process where completely new tissue replaces the 
original cartilage during maturation (Hunziker 2007). 
It appears that the amount of PGs per volume does not vary in a large 
scale during different developmental stages from newborn to adult 
(Williamson 2001) or the amount of PGs slightly decreases (Roughley 
1980, Williamson 2003). Structural variations have also been detected, 
including decrease in the size of the PG subunit, change in the relations 
of GAGs and modifications in the GAGs during maturation (Roughley 
1980).  
All these changes form a response to the loading of the joints, and 
contribute to the mechanical properties of the articular cartilage. A 
significant increase in the tensile stiffness during the maturation has been 
measured, and it follows the increased collagen content and 
modifications (Williamson 2001, Williamson 2003). Also the compressive 
properties undergo significant alterations. The articular cartilage has 
been shown to become stiffer during maturation (Julkunen 2009, 
Williamson 2001), as the permeability of the tissue decreases 
simultaneously (Williamson 2001). These changes in the compressive 
properties correlate with the GAG content (Sah 1997), or collagen content 
(Williamson 2001), and it is probable that both of these constituents 
contribute to the stiffening of the material. 
Several studies show that the amount of exercise has significant effects 
on the quality of articular cartilage, especially in the youth (Helminen 
2000). Moderate exercise is considered to be beneficial for developing 
cartilage (Kiviranta 1988), while too strenous (Arokoski 1994) or too little 
(caused by immobilization) (Haapala 1999, Jortikka 1997) of physical 
exercise can weaken the quality of this tissue.  
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2.3 CARTILAGE INJURIES AND REPAIR 
If articular cartilage is damaged, it does not regenerate spontaneously in 
adults. Sometimes repair tissue may be produced, but the quality of the 
repair tissue is often fibrous, and it begins to degrade later on. Whereas 
cartilage injuries are rather common, a range of repair techniques have 
been adopted in attempt to restore function, relieve patient’s pain and 
prevent further degeneration and development of osteoarthritis. 
 
2.3.1 Cartilage injuries and spontaneous repair 
Technically, cartilage is injured if the capacity of the articular cartilage to 
withstand mechanical forces is exceeded. The capability to bear 
mechanical loads differs between individuals, and is subjected to 
temporal and long-term changes during growth, maturation and aging.  
Several factors can weaken the quality of the cartilage, such as 
developmental disorders (Buckwalter 1998a), excessive exercise or 
immobilization (Arokoski 1994, Haapala 1999), and these can predispose 
cartilage to injuries. However, also healthy cartilage may be injured 
during high-intensity impact that directly, or indirectly in conjunction 
with other impairments of joints, such as meniscal or ligamental ruptures 
damage the cartilage (Buckwalter 1998, Johnson 1998). The incidence of 
cartilage defects is rather high. According to a large study, which 
evaluated knee arthroscopies, 63% of the patients had lesions in hyaline 
cartilage (Curl 1997). Cartilage injuries can vary from minor damage of 
the cells or tissue, without disruption of the cartilage surface, to more 
severe fractures and lesions that tear the cartilage (Buckwalter 1997). The 
clinical symptoms and repair process in these injuries differ in relation to 
the magnitude and depth of the injuries (Newman 1998). Cartilage 
lesions are referred as chondral, if the cartilage tissue is injured, but the 
subchondral bone plate is intact. Chondral injuries can be of partial or 
deep thickness. If the injury penetrates through the whole cartilage layer 
down to the underlying subchondral bone, the defect is called an 
osteochondral lesion. Whilst smaller, non-distruptive traumas can be 
asymptomatic, usually the more severe chondral and osteochondral 
defects cause clinical symptoms, such as swelling, locking of the joint, 
activity-related pain and dysfunction in joint movement to varying 
extents.  
There are certain processes that take place after chondral injury.  
Chondrocytes close to the margins of the trauma area have shown to 
undergo necrosis and or apoptosis (D'Lima 2001a, Kurz 2004). These 
findings are associated with increased levels of matrix-degrading 
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enzymes, which have been measured from the synovial fluid 
(Tchetverikov 2005), and a decrease in the production of ECM molecules, 
such as type II collagen and aggrecan (Kurz 2005, Lee 2005). Increased 
production of catabolic enzymes leads to elevated amounts of loose 
GAGs (D'Lima 2001a) and type II collagen degradation products are 
released into the synovial fluid (Lohmander 2003). Althought there are 
several degrading processes going on after cartilage injury, certain 
constructive actions also take place. It has been shown that individual 
chondrocytes near the chondral defects are activated, start to proliferate 
and produce new ECM to some extent. In addition some repair cells are 
reported to show up and cover the surface of the lesion (Hunziker 1998, 
Newman 1998). Unfortunately, these events appear to be temporary and 
do not lead to significant healing. These migrating repair cells were 
originally thought to be from synovium (Hunziker 1998), but recent 
findings imply that they can also be identified as the chondrogenic 
progenitor cells that originate from the superficial layers of cartilage, 
which activate during injury (Hattori 2007, Seol 2011).  
The damage of the integrity of the collagenous network and loss of 
PGs, either directly by the mechanical injury or during post-traumatic 
catabolic processes, highly affects the tissue. As a consequence the 
mechanical properties of the cartilage change causing failure of function 
(Lu 2008, Quinn 1998). There is evidence that small chondral defects do 
not fill up with repair tissue in adults (Buckwalter 1997, Kim 1991). There 
is some controversy about how the injury then develops; it is either 
thought to lead to further destruction of the cartilage (Brown 2006), or the 
injured tissue has been reported to remain stable over time (Newman 
1998). In conclusion, the chondral injuries induce several catabolic and 
anabolic reactions, but these changes in metabolism are not helpful in the 
regeneration of the tissue, and the spontaneous repair remains poor or 
non-existent.  
Osteochondral defects penetrate the subchondral bone and therefore, 
gain access to the bone marrow cavity and the multipontent 
mesenchymal stem cells (MSCs) in there. In this case, the small arteries in 
the bone are violated and this allows blood to flow in, and the formation 
of a fibrin clot further traps the cells into the defective site (Newman 
1998). After a while, a spontaneous repair tissue resembling hyaline 
cartilage appears (Shapiro 1993). However, the repair seems to be only 
transient. As time goes on the repaired tissue gradually becomes fibrous, 
the chondrocytes alter their production of type II collagen into type I, and 
eventually the new tissue degenerates over time. (Shapiro 1993). 
Furthermore, the integration of the repair tissue into the adjacent 
cartilage is usually partial. Finally, many other factors restrain the 
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regeneration and re-construction of new tissue, such as the anti-adhesive 
properties of the PGs (Englert 2005, Schaefer 2004). 
Major factors that limit the repair in the chondral lesions are 1) the 
localization of chondrocytes trapped in the ECM and their inability to 
migrate into the defect, 2) failure of other migrating cells to adhere and 
produce new tissue, and 3) lack of blood vessels that bring along cells, 
cytokines and growth factors. But as previously shown, not even the 
occurrence of blood and proliferative cells does not usually have the 
desired effect (on the osteochondral defects), and there must be also other 
factors that diminish the capability of articular cartilage to repair. One of 
them might be the secretion of the catabolic, degrading enzymes 
(Tchetverikov 2005) that are on the one hand needed for the modification 
of the injured tissue, but at the same time can be harmful for the 
generation of new tissue. The difficulties in the integration of the repair 
tissue into the adjacent native tissue are easier to understand, when 
considering the arch-like structures of the collagen fibrils and entrapped 
PGs. Succesful integration would require novel collagen molecules to 
protrude into the existing cartilage in a very delicate and site-dependent 
manner that would allow the anchoring of the new tissue into the native 
one and permit fusion between the two.  
It is possible that there are several factors that together hinder the 
repair in the cartilage injuries and cause the osteochondral repair tissue 
to degenerate. Perhaps the novel tissue is too soft and does not withstand 
the high forces generated in the movements (Kisiday 2004, Levin 2005). 
Alternatively, the quantities of degrading enzymes are too much for the 
developing tissue, or the poor integration and impaired barrier fluid film 
in the superficial zone worsen the hydrostatic properties of the tissue and 
therefore make it mechanically unstable. Additionally, inflammatory 
responses may have an effect to the repair of the tissue (Namba 1998). 
 
2.3.2 Osteoarthritis (OA) and cartilage degeneration  
Once the tissue is injured it becomes more vulnerable to degeneration 
and development of posttraumatic osteoartritis (OA) (Brown 2006). The 
end result of posttraumatic OA resembles that of idiopathic primary OA, 
which is defined as a degenerative joint disease that affects all tissues of 
the joint. The disease is also known as degenerative arthritis or 
osteoarthrosis. The following features are linked to this condition: 
fibrillation and erosion of articular cartilage, osteophyte formation, 
subchondral bone sclerosis and synovial hyperplasia, fibrosis and 
inflammatory cell infiltration, although occurrence of these differs among 
patients (Buckwalter 1998a). At the molecular level, increased amounts of 
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degradative enzymes (Tchetverikov 2005), cartilage degradation 
products (Lohmander 2003), together with increased synthesis of ECM 
and inflammatory responses, can be observed (Dieppe 2005). The 
expression of type I collagen has been shown to increase in the 
osteoarthritic cartilage at the mRNA levels (Gebhard 2003, Martin 2001), 
and it is thought to indicate the tendency of the chondrocytes to repair 
cartilage injuries with fibrocartilaginous tissue. The pathogenesis of the 
OA is not fully understood, but once the degeneration has been initiated, 
it can progressively destroy the cartilage and weaken the function of the 
joint. Musculoskeletal disorders are one the most common causes to visit 
a physician, and the prevalence of knee OA is 6% in men and 8% in 
women in Finland according to a large survey (Arokoski 2007). At the 
moment there are no repair methods for OA, which would prevent the 
degeneration to proceed and restore lost cartilage, only palliative 
treatments (Dieppe 2005). Patients with posttraumatic OA are usually 
present with the disorder at a younger age. This further emphasizes the 
urge to generate cartilage tissue repair methods to prevent the 
development of OA after injury. 
 
2.3.3 Methods of repair in cartilage injury 
The earliest methods used to alleviate the pain and gain better 
functionality after cartilage injury included shaving and debridement of 
damaged cartilage. However, the relief in this case is only temporary, as 
the shaving does not stimulate repair. On the contrary, it can cause 
increased fibrillation and necrosis in the adjacent cartilage (Hunziker 
2002, Kim 1991, Newman 1998). However, because the cleaning of flaps 
of fibrillated or injured cartilage can prevent mechanical problems as 
locking of the joints and further promote pain relief, this method is still 
used, when necessary (Gomoll 2010). Since osteochondral defects have 
the ability to repair at least to some extent, different surgical techniques 
have been developed where subchondral bone is surgically penetrated in 
lesions, which were originally chondral only in nature. These methods 
include drilling of multiple holes or creation of microfractures with an 
awl in the lesion site (Mithoefer 2005). The downside of these methods is 
the degeneration and deterioration of the repair tissue over time, a 
similar response detected in the spontaneous repair of osteochondrol 
defects (Hunziker 2002).  
More drastic therapeutic interventions are those utilizing tissue or 
cellular transplantion to the defect site. Tissue transplantation techniques 
include transplantation of periosteal tissue or a graft containing bone and 
cartilage, called an osteochondral transplant (also known as mosaicplasty) 
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(Hangody 1998). The periosteal or perichondrial tissue potentially 
contains cells, which are capable of chondrogenic (and osteogenic) 
activity and, therefore, be able to promote the production of hyaline 
cartilage after the periosteal flap is sutured or glued on top of the 
cartilage defect in a surcigal procedure (Hunziker 2002, Newman 1998). 
However, the repair quality has not been satisfactory when using the 
perichondrial graft: deficient filling of the lesions, calcification of the 
cartilage and overgrowth has been reported, although symptomatic relief 
from pain is generally good (Bouwmeester 1997). In osteochondral 
transplantation a plug containing cartilage and bone is isolated from the 
less-weight bearing area of the joint and transplanted into the defected 
cartilage site (Hangody 1998). The downside of this procedure is obvious; 
it requires removal of osteochondral tissue from healthy cartilage sites 
and causes further destruction of the joint (Hunziker 2002). Additionally, 
the integration of the transplanted graft has been shown to be 
problematic and the quality of the repair tissue deteriorates over time in 
the patients (Bentley 2003). Damage to the healthy tissue in the patient 
can be avoided, if fresh osteochondral allograft transplantation (OAT) 
technique is used. With the OAT technique it is also possible to use tissue 
from similar, collateral location from an organ donor. The osteochondral 
allograft transtplantation have shown good results (Gross 2005), but the 
disadvantages include high costs, and troubles in the cell viability during 
transportation and surgery, as well as difficulties in finding suitable 
donor cadavers. 
A more advanced tissue transplantation procedure is the autologous 
chondrocyte transplantation (ACT) method. In the ACT cartilage is first 
harvested from the less-weight bearing joint area. The chondrocytes are 
then isolated and multiplied in cell culture conditions prior to the second 
operation, in which the isolated cells are transplanted into the cartilage 
defect site underneath a periosteal or collagen flap (Brittberg 1994, 
Gomoll 2010). This method takes advantage of the chondrocytes’ capacity 
to multiply and continue the production of ECM when they are released 
from their native ECM. Relief of pain and improved movements, 
accompanied with arthroscopic findings of hyaline cartilage resembling 
tissue, were reported in a nine year follow-up after ACT (Peterson 2000). 
The clinical outcome after ACT has been compared to microfracture by 
Saris et al (Saris 2009) and Knutsen et al (Knutsen 2007). In the study by 
Knutsen et al, both methods provided satisfactory results in 77% of the 
patients, and there were no significant differences in the clinical and 
radiographic results between the two treatment groups, and no 
correlation between the histological findings and the clinical outcome 
after five years (Knutsen 2007). However, when ACT was performed 
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using specially selected chondrocytes and characterized chondrocyte 
implantation (CCI), the results showed greater improvement in the CCI 
group of patients than in the microfracture group after 3 years follow up 
(Saris 2009). Furthermore subchondral bone reaction was better in CCI 
patients and it was concluded that chondrocyte quality and also time to 
treatment were shown to affect outcome. (Saris 2009). It has also been 
noted that the site and size of the lesion, the existence of other 
impairments of the joint and the age of the patient affect the outcome of 
the ACT (Knutsen 2007, Peterson 2000).  
In the case of advanced OA or severe chondral or osteochondral 
defects, the last option for recovering functions is total joint arthroplasty, 
if other treatment methods have not been useful. Total joint replacement 
alleviates the pain and helps to gain better motility, but because the 
materials tend to wear off, especially in active patients, it is not 
recommended for younger patients. (Carr 2012). 
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2.4 TISSUE ENGINEERING AND BIOMATERIALS 
The term tissue engineering (TE) covers a vast field of research and 
medical practices where tissues or organs are attempted to regenerate by 
delivering implanted cells, scaffolds, DNA, and/or proteins during 
surgical procedures in order to restore tissue morphology and function. 
This field emerged at the end of 1990’s, and it uses a multidisciplinary 
approach, combining knowledge of cell and developmental biology, 
biomechanics, biomedical engineering, as well as material and 
transplantation sciences. (Getgood 2009). The current approaches in 
articular cartilage TE can be categorized into three technical routines 
where A) cells are combined with biomaterials and subsequently 
transplanted, B) cells are combined with biomaterials and pre-cultivated 
prior to transplantation, or C) biomaterial without cells is implanted 
(Figure 4).  
 
 
Figure 4. Principles of cartilage TE. First the autologous or donor cells are 
isolated and multiplied in cell cultures. The regeneration techniques include 
the following: A) cells are combined with biomaterial and transplanted 
straight after, B) cells and biomaterials are pre-cultivated in cell culture or 
bioreactor prior to transplantation, or C) acellular biomaterials are used.         
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2.4.1 Cartilage regeneration 
It is apparent that the adult cartilage lacks functional mechanism to 
produce mechanically stable tissue and the spontaneous repair produces 
fibrous tissue prone to degeneration (Buckwalter 1998a). However, 
during embryonic development cartilage exhibits fast growth and also 
capability to regenerate (Goldring 2006), which was shown in a study 
where superficial cartilage defects created in fetal lambs and were left to 
heal in utero producing completely healed tissue after 28 days (Namba 
1998). These findings suggest that articular cartilage regeneration might 
require an environment that mimicks the fetal events, and if possible, 
trying to prevent the inefficient spontaneous repair process (Caplan 
2003).  This task is not easy to conquer, as the embryonic development is 
a complex process largely unknown and the factors that determine 
wheter the cartilage develops into permanent type or transient to 
undergo hypertrophy, are also not understood. Therefore, with the 
current methods the regeneration of articular cartilage might be 
unreasonable task, and instead the realistic goals for cartilage TE might 
be to produce a repair tissue that withstands for a prolonged time and 
provides at least satisfactory functioning of the joints (Reinholz 2004). 
2.4.2 Cell sources for cartilage tissue engineering 
Different cell sources have been tested for articular cartilage TE. The 
optimal cells to be implanted or transplanted would be capable of 
producing new ECM similar to the native articular cartilage, and to be 
able to withstand the harsh circumstances that are present in the 
cartilage- the low oxygen and nutrients levels and high mechanical loads. 
The strict requirements narrow the candidates to either chondrocytes or 
undifferentiated stem cells. 
Autologous chondrocytes are the earliest cell type that has been used 
for TE purposes in humans (Brittberg 1994). The chondrocytes would be 
the natural option as a cell source, as they are already programmed to 
produce cartilage ECM and suitable for the environmental challenges 
present in the organ. The drawbacks to this route are the associated 
dedifferentation during monolayer expansion (Brodkin 2004), and the 
tendency to produce fibrous repair tissue (Hunziker 2002). The 
chondrocytes can be isolated from the less-weight bearing cartilage of the 
patient (autologous chondrocytes), but then the disadvantage is the 
destruction of otherwise healthy tissue. The use of donor, allogeneic cells 
could be another option, since the studies of osteochondral allografting 
have shown that immunorejection is not a problem (Williams 2007). 
Stem cells are cells with multipotent differentiation capacity. There are 
number of stem cell sources available, and adult mesenchymal stem cells 
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(MSC) have been especially investigated for cartilage TE (Getgood 2009). 
In adults, the MSCs are present in different tissues as a progenitor cell 
reserve populations. The MSCs in their undifferentiated stage will need 
instructions in the form of growth factors, cytokines and other 
environmental cues (load, suitable ECM and others) to start and continue 
the progress of differentiation (Caplan 2003). They can be harvested and 
isolated from adult bone marrow, adipose tissue, muscle, periosteum or 
synovium (Hunziker 2002), and then manipulated in cell culture 
conditions using specific growth factors to differentiate them into 
chondrocytic cells (Worster 2001) or directly transplant MSCs without 
differentation. A follow-up of 227 patients who underwent autologous 
bone marrow derived MSC therapy showed no neoplastic complications 
(Centeno 2010, Pelttari 2008). However, other studies are raising question 
about the tendency to undergo hypertrophy and development of 
vascularization in the MSC – derived chondrocytes in vivo (Pelttari 2008). 
Therefore, the use of MSCs as progenitor cells for cartilage restoration 
still needs further development. 
There is also a vast field of ongoing research on optimization of cell 
culture conditions, for example to overcome the chondrocytes tendency 
to dedifferentiate during cultivation. It has been shown that the 
chondrocytes grown in monolayers lose their phenotype after longer 
culture periods (Brodkin 2004). Therefore, it has been investigated 
whether this adverse event could be avoided by manipulating the cell 
culture conditions, such as different oxygen level conditions (Murphy 
2004), growth factors combinations (Chaipinyo 2002, Tew 2008), 
mechanical stimuli (Smith 2004), or three-dimensional scaffolds 
(Frondoza 1996) during cultivation. The use of bioreactors to cultivate 
cells alone or cells combined with biomaterials has gained much 
attention. The use of a bioreactor allows the tissue or cells to be exposed 
to mechanical stimuli, and improves the exchange of nutrients and waste 
products. (Risbud 2002). Bioreactors have been shown to increase the 
production of ECM in chondrocytes cultivated in a biomaterial, in 
comparison to static cultivation (Vunjak-Novakovic 1999). Other 
researchers have demonstrated increased stiffness, GAG and collagen 
content in chondrocyte-seeded hydrogel constructs cultivated in a TE 
bioreactor that applies daily cyclic compression. (Mauck 2000). 
 
2.4.3 Biomaterials as scaffolds 
Biomaterials are biocompatible materials that can be transplanted into 
human body without adverse effects. The materials are usually 
biodegradable and they offer initial support to chondrocytes in cartilage 
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TE. An optimal degradation process would proceed at the same pace new 
ECM is produced to replace the biomaterial (Caplan 2003). Biomaterials 
can be used as a scaffold for the chondrocytes or MSCs to promote the 
filling of the lesion, cell attachment, growth and differentiation in 
cartilage repair. There are several requirements for a good biomaterial: 1) 
the material and its degradation products need to be safe and non-toxic, 
2) material should allow cell growth, exchange of oxygen, nutrients and 
waste products, and 3) material should provide mechanical support for 
the cells and help to fill the lesion site, and 4) material should offer 
attachment sites for ECM-receptors, that promote cell growth and 
prevent apoptosis (Getgood 2009). 
Some biomaterials are used without cells (Gibson 2006, Steinwachs 
2008), and the repair cells are then supposed to migrate into it from 
elsewhere. For example, cells from subchondral bone are exposed using 
the microfracture technique, and thay can inhabit the scaffold after 
transplantation (Benthien 2010, Steinwachs 2008). However, several 
applications take advantage of combining cells and biomaterials in order 
to grow new cartilage (Sittinger 2004).  
There is no consensus amongst researchers about the optimal 
mechanical properties of the biomaterial for cartilage TE. Whether the 
materials should be hard for maximum support, or soft to allow cell 
seeding and growth, remains an open question. Some experts consider 
that the biomaterial should possess similar mechanical properties as 
adult articular cartilage. However, because of the special nature of this 
tissue this is not easily achieved and, by far, no such materials exist.  The 
mechanical properties of the biomaterial are further complication. A hard 
material would provide better mechanical support, but this could lead to 
problems in cell seeding or submersion of the material into the 
subchondral bone (Pulliainen 2007), or detachment of the transplants 
(Vasara 2004). On the other hand, soft biomaterials such as hydrogels do 
not provide much support, but allow even cell seeding and growth of the 
transplant (Sittinger 2004).  
Biomaterials that have been tested in vitro or in vivo, or are currently 
used as a repair method, can be categorized into natural materials or 
synthetic polymers. They have been developed in different formulas: 
sponges, woven scaffolds, fleece-like fabrics, or hydrogels. Hydrogels are 
networks of polymers containing large amounts of water. Because of the 
vast field of biomaterials, only the most popular or promising materials 
are presented in Table 1. Good reviews of different biomaterials are 
available (Hunziker 2002, Getgood 2009). The synthetic materials can 
offer good possibilities to formulate the structure and shape of the 
scaffold, but they can cause foreign body cell reactions and poor cell-
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adhesion (Chu 1995, Hunziker 2002). Natural materials, especially those 
that naturally occur in the cartilage ECM, can offer a more familiar 
environment for the chondrocytes, and most importantly they provide 
attachment sites for the ECM-receptors, such as integrins, and can 
therefore inhibit apoptosis (Hirsch 1997). Collagens, especially, facilitate 
cell adhesion, enhance the growth and differentiation of cells (Kleinman 
1981) while HA can be chondroinductive and antiangiogenic (Caplan 
2003). Therefore, the most intensively studied natural materials and those 
that already have techniques in clinical practice for human patients are 
collagens in different formulas (Bartlett 2005, Frenkel 1997, Gibson 2006, 
Steinwachs 2008) and hyaluronan based matrices (Nehrer 2006, Solchaga 
1999). The disadvantages of using the natural materials are the problems 
in shaping the matrix, the relatively soft form of their unprocessed state, 
and the availability of the materials. Most often the collagens are isolated 
from tendons or connective tissue from cattle or pigs, and they are 
usually type I or III collagens, not type II, which is present in articular 
cartilage (Kleinman 1981). Hyaluronan can be obtained from rooster 
combs or from specific bacterial cultivations (Widner 2005). The use of 
any animal-derived materials raises concerns about safety and poses a 
risk for allergic reactions. (Hunziker 2002)  
 
Table 1. Examples of biomaterials that are currently tested for articular 
cartilage tissue engineering in in vitro studies, in vivo animal experiments, or 
in vivo clinical studies in humans.   
 
 
Material Formula Studied Findings Reference 
Synthetic     
 Polylactide 
acid (PLA) 
porous 
matrix 
in vivo, 
rabbits 
cartilaginous tissue after 
6 weeks 
(Chu 1995) 
Natural     
Agarose 
 
gel in vitro human chondrocytes 
maintained phenotype in 
long-term culture, but 
slowed down growth, 
retained ECM expression 
(Kolettas 
1995) 
Alginate 
 
beads in vitro bovine chondrocytes 
maintained phenotype in 
long-term culture 
(Häuselmann 
1994) 
Cellulose, 
bacterial 
 
sponge in vitro bovine chondrocytes 
were viable in short-term 
culture 
(Svensson 
2005) 
Chitosan 
 
coated 
surface 
in vitro human chondrocytes 
were viable in short-term 
culture (7 days) 
(Lahiji 2000) 
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Collagen, type 
I, porcine 
 
 
gel in vivo, 
rabbits 
hyaline-like repair tissue 
was detected after 6 
months 
(Kawamura 
1998) 
Collagen type I, 
CaRes-1S®, 
from rat tail 
 
gel in vivo, 
humans 
complete filling of the 
lesion and improved 
clinical outcome after 24 
months in nine patients 
(Efe 2011) 
Collagen type I, 
from rabbit skin 
gel in vivo, 
rabbits 
hyaline-like repair tissue 
was detected after  24 
weeks 
(Wakitani 
1989) 
Collagen type I 
and III, 
porcine, called 
Chondro-Gide® 
bilayered 
membrane 
in vivo, 
rabbits 
hyaline-like repair tissue 
was detected after  24 
weeks 
(Frenkel 
1997) 
Collagen type 
II, from bovine 
+ polyethylene 
glycol (PEG) 
 
gel in vivo, 
rabbits 
hyaline-like repair tissue 
was detected after 24 
weeks 
(Funayama 
2008) 
Collagen type I 
and III, 
procine, called 
MACI®  
bilayered 
membrane 
in vivo, 
humans 
hyaline-like repair after 1 
year in 36.4% patients, 
excellent clinical outcome 
in 19% 
(Bartlett 
2005) 
Fibrin, called 
Tisseel® 
 
adhesive 
gel 
in vivo, 
rabbits 
impaired the natural 
repair, prevents cell 
migration 
(Brittberg 
1997) 
Hyaluronan 
(HA), HA 
benzyl-ester, 
called HYAFF® 
or Hyalograft 
C® 
non-woven 
mesh 
in vivo, 
humans 
improved functional 
outcome 3 years post-
operatively 
(Nehrer 2006) 
 
2.4.4 Assessing the repair methods and some future aspects 
The assessment of the different biomaterials is rather difficult. All 
different matrices offer some good qualities and many studies report 
initially promising results in vitro, but unfortunately long-term repair of 
articular cartilage defects often faces the same end-result than the 
spontaneous repair: fibrillated and detoriated cartilage (Bartlett 2005). For 
analyzing the quality of the biomaterial, different in vitro and in vivo 
assessments are used. After the cells and biomaterials are cultivated in 
vitro or in vivo, the experiments are usually evaluated using different 
methods to analyze the cellularity or phenotype of the cells, the ECM 
production and structure, and mechanical properties of the products. In 
human studies the patients are also questioned about pain and ability to 
function. 
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The cultivation of isolated chondrocytes or MSCs is often needed to 
multiply the cells for cartilage TE, and the research done in cell culture 
systems in vitro has also provided many insights into the proliferation 
and differentiation of chondrocytes (Reinholz 2004). When novel 
biomaterials or TE methods are tested, the first step is usually in vitro 
cultivation under static conditions or in bioreactors to gain better insight 
on how the cells react. Primary chondrocytes, or chondrocytes passaged 
only a couple of times, are used in these experiments. The suitability of 
the biomaterial for chondrocyte cultivation is then detected using various 
microscopical and biochemical assays to assess cell viability, growth 
properties and ECM constituent production at both the RNA and protein 
levels. 
If the preliminary in vitro studies confirm the usability of the TE 
method, then the material is usually tested in vivo, to further investigate 
how the material is reacting in living conditions. A heterotopic 
chondrogenesis model that uses immunocompromised nude mice has 
been developed to test the chondrogenic potential of the TE therapeutical 
methods in vivo (Dell'Accio 2001, Pelttari 2006, Silverman 1999, Solchaga 
1999). The TE constructs are usually implanted under the back skin of the 
nude mouse. While the conditions in subcutaneous cultivation do not 
correspond to the circumstances present in joints, these studies offer an 
important first sight in vivo information, before more expensive animal 
studies with more effort are conducted. (Reinholz 2004). 
Finally before the TE applications are accessible to be used on patients, 
the ability of the construct to produce repair tissue in actual defects needs 
to be proven in a larger animal model. Cartilage reconstruction has been 
studied in murine, lapine, canine, caprine, porcine, and equine models 
(Ahern 2009). Each model possesses advantages and disadvantages. The 
smaller species, such as mice, rats and rabbits are cheap to maintain, easy 
to handle and useful in the preliminary phase of studies. However, the 
smaller size of the joints and good spontaneous repair limit their 
usability. Larger animals, such as goats and minipigs provide larger 
joints, but still smaller than in humans, and their usage brings greater 
logistical, financial and ethical problems (Chu 2010). Althought none of 
the existing animal models are flawless, they are still needed in the future 
alongside with in vitro modeling, when developing surgical or 
therapeutical methods for cartilage TE.  
The assessment of the repair quality in the animal models often 
includes description of the macroscopical observations of the repairs and 
surrounding tissue, microscopical and/or biochemical analyses of the 
ECM and chondrocytes, and biomechanical testing of the repaired tissue. 
The microscopical methods usually include use of various histologic dyes 
29 
 
 
for detecting different compartments of the tissue, and they provide 
illustrative data that can be used for quantification or scoring of the 
repair tissue quality. Scoring protocols are used to gain a more objective 
and comparable view of the repair quality (Mainil-Varlet 2003). For 
animal models, a scoring protocol developed by O’Driscoll and 
colleagues (O'Driscoll 1988) or Mankin and co-workers (Mankin 1971) 
have been used. In the O’Driscoll scoring protocol, usually several 
investigators individually grade blinded samples, investigating the 
cellular properties, nature of the predominant tissue, structural integrity, 
fibrillation and bonding to the adjacent cartilage. 
In summary, research has really increased the knowledge about the 
potential of regenerative medicine in aiding articular cartilage repair. 
However, there are still many challenges for restoring the functionality of 
injured cartilage. Important goals for future studies include: 
 
x determining the causes of repaired tissue degeneration 
and finding remedies to prevent it 
x finding a method to promote intregration of the 
repaired tissue into the existing adjacent host tissue 
x developing novel biomaterials that would promote 
healing in a clinically efficient  way 
x research the development of the multilayered 
structure of articular cartilage and finding a way to 
promote this in the repair tissue. 
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3 Aims of the study 
The normally functioning articular cartilage offers smooth movements of 
the joints, but when injured it’s spontaneous healing capacity is very 
limited. Currently no simple and good method is availlable that would 
guarantee regeneration and the subsequent healing of injured cartilage. 
Articular cartilage TE using biodegradable scaffolds for chondrocytes 
could help the restoration of functional tissue. The use of type II collagen 
as a scaffold material for chondrocytes has been extensively studied 
because it would offer a natural surrounding for the cells that could 
promote cell survival and phenotype maintenance. Type II collagen has 
been previously tested for TE with good results. The collagen material 
that has been previously tested was extracted from animals. If human 
collagen, manufactured with recombinant techniques, could be used 
instead, it would provide a reliable and animal component-free source of 
biomaterial. 
 
The main aim of this thesis was to test a novel material; recombinant 
human type II collagen (rhCII) as a biomaterial for chondrocytes. The 
specific aims were the following: 
 
 
1. To explore different techniques and a variety of formulas of the 
rhCII, e.g., sponges, membranes and hydrogels, and their 
usability as a coating for other scaffolding materials (Studies I, 
II). 
 
2. To determine and test the suitability of the rhCII material for 
chondrocyte cultivation in vitro (Studies I, II). 
 
3. To investigate the feasibility of the developed method and 
formula of rhCII as a chondrocyte-seeded scaffold in vivo in 
terms of cellular, ECM and biomechanical properties (Studies 
III, IV). 
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4 Materials and methods 
This thesis consists of four independent studies (Figure 5), in which rhCII 
was tested for articular cartilage TE purposes using various methods to 
analyze the structural, biochemical and biomechanical properties of the 
constructs. In the preliminary studies, the rhCII was used as a membrane 
or sponge-like scaffold for chondrocytes (results published by Tiitu 2008). 
Secondly, the rhCII was used as a coating material for cellulose scaffolds 
and chondrocytes were cultivated in it in vitro (study I). From then on, 
the rhCII-material was tested as a gel-like scaffold for chondrocytes, first 
in vitro (study II), and then in vivo in a nude mouse model (study III), and 
in a cartilage defect repair study in rabbits (study IV), to investigate the 
suitability of the rhCII material for cartilage TE.  
 
 
 
Figure 5. Outline of the thesis project.  
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4.1 BIOMATERIALS  
4.1.1 Recombinant human type II collagen (rhCII) and other 
recombinant human (rh) collagens  
Type II collagen has been previously tested and proven to be suitable for 
cartilage TE (Funayama 2008, Nehrer 1998). The rhCII-material was 
provided by a Finnish company- Fibrogen Europe Oy (Helsinki, Finland). 
They manufactured this material using recombinant DNA technology in 
yeast cultivations (Pichia pastoris). The product was then purified and 
dissolved in 10 mM HCl prior to further use. This process has been 
described by Myllyharju and colleagues (Myllyharju 2000). In brief, the 
manufacturing process utilizes gene transfer of cDNA for human 
procollagen α1(II) into the yeast cells which coexpress recombinant prolyl 
hydroxylase (Nokelainen 2000, Olsen 2003). The recombinant prolyl 
hydroxylase catalyzes hydroxylation of prolines in the recombinant α-
chains and has been shown to result in stable triple-helix formation of the 
α-chains that leads to the production of the procollagen molecule (Baez 
2005, Olsen 2003). After harvesting the recombinant procollagen, it is 
treated with a protease that removes the N- and C-propeptides and 
allows formation of spontaneous aligned of collagen fibrils in neutral pH 
with close resemblance to native tissue-derived collagen (Olsen 2003). 
The recombinant collagen was then used either as a sponge (Tiitu 
2008), a membrane (Tiitu 2008), a coating for cellulose (study I) or a gel-
like scaffold (studies II, III, IV). In preliminary studies, recombinant 
collagens I and III (Fibrogen Europe Oy, Helsinki, Finland) were also 
tested, and as a result it was decided to continue using the rhCII material 
for further studies (results presented in study III and by Tiitu 2008). 
 
4.1.2 RhCII-coated cellulose scaffolds (study I) 
Cellulose is a naturally occurring linear polysaccharide. It functions as a 
structural component in green plants and some bacteria. It is insoluble in 
water and degrades slowly when implanted in the human body (Martson 
1999). Bacterial cellulose was recently introduced as potential scaffold for 
cartilage tissue engineering (Svensson 2005). In study I, viscose cellulose 
sponges® (Cellomeda, Turku, Finland) were used. The material has been 
developed to investigate wound healing, and these scaffolds are 
biocompatible and homogeneous sponge-like matrices (Pajulo 1996). The 
cellulose sponges were tested with and without rhCII-coating on the 
surface. For the coating procedure, the sponges were immersed in a 
solution of type II collagen (3.49 mg/ml) in 10 mM HCl for ten minutes 
and afterwards snap frozen in liquid nitrogen. After freezing the sponges 
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were freeze-dried under a vacuum, overnight, and subsequently cross-
linked with a glutaraldehyde vapour treatment for 4 hours at 37°C. 
Unreacted aldehyde groups were blocked with 0.1 M glycine  for 30 
minutes and the sponges were then washed with deionised water, and 
further freeze-dried overnight (Chen 2003). Before cell seeding the 
sponges were sterilized with 70% ethanol, washed with sterile water and 
dried.  
4.2 CHONDROCYTE ISOLATION, CULTURING AND 
VIABILITY ASSAYS 
 
Freshly isolated bovine chondrocytes without precultivation were used 
in studies I, II and III. In the fourth study, autologous rabbit 
chondrocytes were used: rabbit cartilage was isolated during a surgical 
procedure, chondrocytes were isolated and then multiplied in cell 
cultures before using them in combination with rhCII material to make 
rhCII gels (study IV). 
 
4.2.1 Chondrocyte isolation and cell culturing 
Bovine articular cartilage was harvested from patellofemoral grooves of 
18-month-old cows (Atria abattoir, Kuopio, Finland). Chondrocytes were 
isolated from cartilage slices in a two-step isolation protocol performed at 
37°C and an atmosphere containng 5% CO2. The cartilage was digested 
with 500 μg/ml of hyaluronidase (Sigma, St. Louis, MO, USA) in 
Dulbecco’s modified medium (DMEM, Euroclone, Pero, Italy) for 30 
minutes. In the second digestion step, DMEM containing 300 μg/ml of 
collagenase (Sigma) and 200 μg/ml of DNAase I (Sigma) was used 
overnight. Next day, the cells were washed with phosphate-buffered 
saline (PBS) and suspended in DMEM supplemented with 1% fetal calf 
serum (FCS, PAA, Linz, Austria), 2 mM L-glutamine (Sigma), 200 IU/ml 
of penicillin (Euroclone), 200 μg/ml of streptomycin (Euroclone), 2.5 
μg/ml of fungizone (Sigma) and 50 μg/ml of ascorbic acid (Sigma).  
Rabbit chondrocytes were obtained by harvesting a biopsy of cartilage 
from the margin of the femoral trochlea of the left knee joint. The surgical 
operations were performed under anesthesia (Domitor 0.35 ml/kg, Orion 
Pharma, Espoo, Finland and Ketaminol 0.6 ml/kg, Intervet International 
B.V., Boxmeer, the Netherlands). Subsequently, the cartilage biopsies (10-
20 mg/each isolation) were washed with sterile phosphate-buffered saline 
(PBS). Cartilage was digested with 120 units/ml of collagenase (Sigma) in 
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DMEM at 37°C and 7% CO2 overnight. The next day, the isolated cells 
were washed with PBS and suspended in supplemented DMEM. After 
enzymatic digestion the cells were expanded in culture dishes in an 
incubator at 37°C and 7% CO2, until the desired amount of cells was 
abtained in approximately 2-3 weeks. The expanded cells were 
trypsinized and used for making the hydrogels before transplantation 
into cartilage defects. 
4. 3 THE USE OF RHCII-MATERIAL AS A COATING OR GEL-
LIKE SCAFFOLD 
4.3.1 Cell seeding into rhCII-coated cellulose sponges (study I) 
Freshly isolated bovine chondrocytes were seeded into the sterile 
cellulose scaffolds by adding medium containing 1.225 × 106 cells per 
scaffold. For other experiments, the cells were cultured in scaffolds for 1, 
2, 3 and 4 weeks in 37° and 5% CO2. The viability of the chondrocytes 
was tested using the viability assay described in section 4.7.1. 
4.3.2 Preparation of rhCII hydrogels (studies II, III, IV) 
The cell-seeded collagen gels were made using rhCII solution (3.7 mg/ml 
dissolved in 10 mM HCl) with bovine (study II, III) or autologous rabbit 
chondrocytes (study IV). Collagen is soluble in acidic solution, but when 
the collagen solution is neutralized into pH of physiological level in 37°C 
degrees, the collagen molecules spontaneously arrange into their native 
helical form (Elsdale 1972). The suitable concentration of chondrocytes 
and rhCII-solution was first determined in preliminary studies in vitro 
(data not shown). It was noticed, that when the collagen solution in 10 
mM HCl is diluted 1:1 to medium, the solution was neutralized 
(confirmed with pH meter).  
4.3.3 Chondrocyte seeding into rhCII hydrogels (studies II, III, IV) 
Collagen gels were individually prepared by gently mixing the rhCII 
containing solution and the medium containing chondrocytes at a 1:1 
volume ratio in sterile microcentrifuge tubes. A relatively high cell 
number was used to increase the structural integrity and durability of the 
gel. The number of cells was 1 x 106 per 100 μl of medium, the total 
concentration in the intitial solution then being 500 000 cells in one 
hydrogel. Cell-free controls were made in a similar fashion, but without 
adding cells. Gels were incubated at 37°C and 5% CO2 for 1 hour to allow 
gelation of the collagen. After incubation, the gels were centrifuged at 13 
000 rpm for 2 minutes, and excess liquid was removed. The remaining 
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part (the soft collagen gel with or without the chondrocytes) was then 
transferred to carrier plates on top of cell culture dish (studies II, IV), or 
transplanted into nude mice (study III). The carrier plates, similar to 
those used in histological sample preparation, were used to prevent the 
hydrogels becoming attached to the bottom of the dish and to provide 
support to the hydrogels. The outcome was that hydrogels were floating 
in the supplemented growth medium inside the carriers during the 
cultivation. 
 
4.3.4 Cultivation in vitro (studies I, II) 
Chondrocyte growth medium consisted of DMEM supplemented with 
10% fetal calf serum (PAA, Linz, Austria), 50 μg/ml ascorbic acid (Sigma), 
2 mM L-glutamine (PAA), 20 IU/ml of penicillin (Euroclone), and 200 
μg/ml of streptomycin sulphate (Euroclone). The growth medium was 
added to the dishes, and half of it was replenished with fresh medium 
twice a week. The cellulose sponges were floating in the growth medium 
in cell culture dishes, and the rhCII-gels were cultivated inside the carrier 
plates positioned in the cell culture dishes. 
 
4.3.5 Macroscopic evaluation of the rhCII hydrogels (study I) 
The macroscopic appearance of the rhCII hydrogels was examined 
during the culture time. Typically the collagen gels tend to contract 
during culture (Galois 2006). Therefore, the gels were photographed at 
different time points to estimate the extent of gel contraction. 
 
4.4 ANIMAL EXPERIMENTS 
The study design of the animal experiments was approved by the 
Institutional Animal Care and Use Committee of the University of 
Kuopio and the Provincial Government. 
4.4.1 Nude mouse model (study III) 
Immune-deficient nude mice have been used for various purposes in 
cartilage research. They were first used when chondrocytes from rabbits 
and dogs were injected subcutaneously (Lipman 1983). Since then, nude 
mice have become a commonly used animal model for designing 
matrices for cartilage reconstruction (Munirah 2008, Solchaga 1999), e.g., 
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to testing in vivo chondrogenic cell differentiation and cartilage formation 
(Dell'Accio 2001, Enomoto-Iwamoto 2000). 
In our study nude mice were anaesthesized with 2-4% isoflurane (1-
chloro-2,2,2-trifluoroethyl difluoromethyl ether, Isofluran Baxter, Baxter, 
Lessines, Belgium) before injections. Each mouse (n=24) was treated with 
three subcutaneous injections (Figure 8A): 1) cell-free rhCII gels (rhCII-
gel); 2) bovine chondrocytes in rhCII gel (rhCII-cell); and 3) bovine 
chondrocytes in growth medium (Med-cell). The volume of injections 
was 400 μl that contained 6 million cells. The injection sites were located 
in the back of the mice in a triangular pattern (Figure 8A). No major scar 
formation or skin abnormalities were detected in the injection sites, and 
the animals behaved normally. After 6 weeks, the animals were 
euthanized with CO2, and the constructs and blood samples were 
collected for further analyses. Specimens (24 in each group) were 
collected from these triplicate injections and divided for further analyses. 
The total number of individual specimens was 7-12 in the analysis. 
Samples from rhCII-gel injections could not be used for further analyses, 
since no tissue formation was observed in the implantation sites. 
 
4.4.2 Blood samples from nude mice (study III) 
Blood samples were collected from the mice at the time of death. The 
values of leukocytes, erythrocytes, hemoglobin and thrombocytes were 
analyzed with an automated hematology analyzer (Cell Dyn 3500R, 
Abbott Laboratories, Abbott Park, IL), which has been shown to be a 
reliable and accurate instrument for murine blood analysis (Kieffer 1999). 
Blood of the animals injected with rhCII (n=12) was compared to that of 
the non-injected control animals of the same age (n=10). 
 
4.4.3 Rabbit model for cartilage injury (study IV) 
Rabbits have been widely used as an osteochondral defect model for 
cartilage repair (Brittberg 1997, Christensen 2012, Funayama 2008, Sah 
1997, Willers 2005). To study the feasability of using the combination of 
rhCII and autologous chondrocytes to repair cartilage injuries, 
osteochondral defects (4 mm in diameter and 3 mm in depth) were 
created into rabbits’ femoral trochlea (patellar groove) by drilling. A total 
of 15 mature female New Zealand white rabbits (age 9 months) were 
used for this experiment. Rabbits were randomly divided into two 
groups and defects to the articular cartilage were created, and treated as 
follows: 1) defects were repaired with precultivated rhCII hydrogels and 
previously expanded autologous chondrocytes (rhCII-repair, n=8); and 2) 
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defects were left empty (spontaneous repair, n=7). The repair results after 
6 months were compared with intact patellar groove cartilage samples 
(n=7) taken from the contralateral femurs of the spontaneous repair 
group animals.  
The rabbits in the rhCII-group underwent two surgerical operations; in 
the first operation a biopsy of cartilage for chondrocyte isolation was 
harvested from the margin of the femoral trochlea of the left knee joint 
and multiplied as described in chapter 4.2.1. The expanded cells were 
trypsinized and used for preparation of the gels as follows: 300 μl of 
DMEM containing 3 million chondrocytes was combined with 300 μl of 
rhCII-solution. Excess liquid was removed by centrifuging after 1 hour of 
gelling at 37°C.  
The rhCII cell constructs were cultivated in cell culture conditions for 2 
weeks prior to the next surgical operation to minimize the influence of 
early stage contraction in the gels. The surcigal operations were 
performed under anesthesia (Domitor 0.35 ml/kg, Orion Pharma, Espoo, 
Finland and Ketaminol 0.6 ml/kg, Intervet International B.V., Boxmeer, 
the Netherlands). In the second surgical operation, an osteochondral 
lesion (4 mm in diameter, 3 mm in depth) was drilled into the right 
femoral trochlea (patellar groove) (n=8) and filled with the pre-cultivated 
rhCII-cell construct. Before implantation, the gel grafts were punched 
with a 4 mm biopsy punch (Kai Industries, Oyana, Gifu, Japan). The 
precise size of the gel grafts allowed tight fitting of the implant into the 
defect without any additional fixation. For the spontaneous repair group, 
similar lesions were created (n=7) and left empty. At the end of the 
experiment, the contralateral knees (n=7) from this spontaneous repair 
group were used for harvesting intact tissue from patellar groove as a 
control reference. After 6 months, the animals were killed and the knee 
joints (distal end of femurs) were stored in a freezer (-20°C) in PBS 
containing 5 mM ethylenediaminetetraacetic acid (EDTA; Merck KGaA, 
Darmstadt, Germany), 5mM benzamide-HCl (Sigma St. Louis, MO, USA) 
and 5μg/l phenylmethylsulfonylfluoride (Sigma) as inhibitors of 
proteolytic enzymes, until further analysis. Micro-computed tomography 
(μCT) and biomechanical analyses were performed before histological 
fixation of the samples for tissue imaging analysis. 
 
4.5 METHODS FOR ANALYZING THE RESULTS 
During the thesis project, several methods were used to evaluate the 
properties of the rhCII material as a coating agent, and as a gel-like 
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scaffold for chondrocytes. The used methods for analyzing the results 
and outcome of the studies are listed in the Table 2 below. Specific details 
are presented in the following chapters. 
 
Table 2. Methods used to study rhCII material as a scaffold for chondrocytes 
in the original publications. 
 
Investigated property Study I 
in vitro 
Study II 
in vitro 
Study III 
in vivo 
Study IV 
in vivo 
Cell viability     
   viability assay with confocal         
microscope 
X X X X 
Cellularity     
   hematoxylin staining   X  
Cell morphology     
   SEM X    
Proteoglycans (PGs)     
   safranin O histology  X X X 
   toluidine blue histology   X X 
  PG content with FTIR    X 
   structural PG analysis with 
electrophoresis 
  X  
   PG contents with uronic acid 
analysis 
 X   
   aggrecan expression by RT-PCR  X   
Collagens     
   Col2α1 expression by RT-PCR  X   
   type II (COL2A1) 
immunostaining 
 X X X 
   type I (COL1A1) 
immunostaining 
  X X 
   type X (COL10A1) 
immunostaining 
  X  
   collagen content with FTIR    X  
   collagen parallellsim with e-POL    X X 
   fibril orientation with e-POL    X 
Bone formation and quality     
   alkaline phosphatase histology   X  
   Masson’s trichrome histology   X X 
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   Micro-computed tomography    X 
Mechanical properties     
   mechanical testing X  X X 
4.6 GENE EXPRESSION LEVELS IN CELL CULTURES 
(STUDY II) 
4.6.1 Gene expression analysis by quantitative RT-PCR 
Total RNA was isolated from the bovine chondrocytes grown in 
recombinant human type II collagen gels using Eurozol reagent to 
disrupt the cells (Euroclone). After extraction, 1 μg of total RNA was 
treated with 1 μl of 2 U/μl of Turbo DNA-free DNAase according to the 
manufacturer’s instructions (Ambion, Houston, TX, USA) . 1 μg of DNA-
free RNA samples were then reverse-transcribed into cDNA in a reaction 
mixture containing 10 mM dNTPs, 25 mM MgCl2, 100 mM dithiothreitol, 
random DNA hexamer, RNase inhibitor and Multiscribe Reverse 
Transcriptase in 5 x Reverse Transcriptase (RT) buffer (PE Biosystems, 
Foster City, USA). Expression levels of aggrecan, procollagen α1(II) and 
GAPDH mRNA were analyzed using quantitative real-time PCR 
(Mx3000P, Stratagene, La Jolla, USA). The primers used for PCR are 
listed in Table 3. The PCR analysis was performed in a 25 μl reaction 
volume containing 40 ng of cDNA, 2 x SYBR Green Master Mix and 100 
to 600 nM of each primer. The amplification protocol included a first 
cycle at 95°C for 10 minutes, then 40 cycles at 95°C for 30 seconds, 59-
60°C for 1 minute, and 72°C for 1 minute. The efficiency of the 
amplification was between 90-110% (calculated using the software by 
Stratagene). The melting curve analysis was done after the amplification 
to ensure that only one end-product had been synthesized. The PCR 
products were also analyzed by electrophoresis to estimate that the 
product was of the correct size. The cDNA bands were excised from the 
gels, purified and then sequenced to confirm the presence of the correct 
amplified product. Sequencing was performed by personnel from A.I 
Virtanen Institute for Molecular Sciences (University of Kuopio, Finland) 
using the primers from Table 3. The obtained sequences were verified to 
be correct using the Basic Local Allignment Tool (blast.ncbi.nlm.nih.gov). 
The results of the PCR analysis were normalized using bovine 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a reference 
transcript. 
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Table 3. Primer sequences for the real-time PCR assays. 
 
Gene Primers (5'-3') Product 
size (bp) 
Reference 
Col2α1 TGAGAGAGGGGTTGTTGGAC 
AGGTTCACCCTTCACACCTG 
133 (Galois 2006) 
Aggrecan CACTGTTACCGCCACTTCCC 
GACATCGTTCCACTCGCCCT 
303 (Bosnakovski 2006) 
GAPDH TTCAACGGCACAGTCAAG 
ACATACTCAGCACCAGCATCAC 
119 RTPrimer DataBase ID: 3379   
(http://medgen.ugent.be/rtpri
merdb) 
 
4.7 MICROSCOPY 
4.7.1 Cell viability assay for chondrocytes 
The viability of chondrocytes cultivated in the constructs was evaluated 
using a combination of two fluorescent probes. The specimens were 
incubated for 5 minutes in a solution containing 60 μM concentration of 
cell membrane-impermeable DNA-binding dye, propidium iodide 
(Sigma, St. Louis, MO, USA and 10 μM concentration of cell-permeable 
fluorescein diacetate (Fluka, Buchs, Switzerland) in PBS. After washing 
with PBS, the samples were viewed with a confocal scanner (PerkinElmer 
Life Sciences, Wallac-LSR, Oxford, UK) on a Nikon Eclipse TE300 
microscope, using the wavelengths 488/510 nm (excitation) and 525/550 
nm (emission) for fluorescein, and 568/610 nm (excitation) and 607/645 
nm (emission) for propidium iodide. 
4.7.2 Scanning electron microscopy (SEM) (study I) 
Cell morphology and expansion in the cellulose scaffolds was analysed 
using SEM. After the 4 weeks culture period, the scaffolds were fixed in 
2.5% glutaraldehyde dissolved in 0.1M sodium cacodylate buffer (pH 
7.4). They were subsequently dehydrated step wise through an ethanol 
gradient (50, 70, 80, 90 and 100% ethanol) and finally with hexamethyl-
disilazane. The scaffolds were coated with gold and viewed with Philips 
XL30 ESEM TMP (FEI Company/Oy Philips Ab, Brno, Czech Republic). 
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4.7.3 Preparing the samples for histology and imaging (studies II, III, 
IV)  
The cellulose scaffolds proved impossible to process into histological 
samples, so no histology could be done with the cellulose cultivations. 
The in vitro cultivated rhCII gel constructs were initially very soft, and 
after 4 weeks of cultivation they were firmer, but still difficult to process 
for histology using the conventional methods. Therefore, the in vitro 
cultivated gel samples were fixed overnight in an aquoes solution 
containing 4% formaldehyde and 0.5% Safranin O (Fisher, New Jersey, 
NY, USA) to obtain better preservation of proteoglycans in the samples 
(Kiraly 1996) (study II). For the subcutaneously cultivated samples 
collected from nude mice, the constructs were harder and could be 
processed using the traditional overnight fixation in a 4% formaldehyde 
solution (study III). The tissue repair samples from the rabbits contained 
bone and cartilage dissected from the operated joint, and therefore 
decalcification of the sample was required in order to soften the bone 
(study IV). The rabbit knee joint samples were first sawed into small, 
approximately 1 cm x 0.5 cm x 0.5 cm pieces that contained bone and 
cartilage from the lesion area or equivalent intact tissue. The specimens 
were then fixed in 4% neutral phosphate-buffered formaldehyde solution 
for 24 h. The formaldehyde-fixed samples then underwent a 
decalcification process in 10% EDTA (Merck KGaA, Darmstadt, 
Germany) that took place for several weeks.  
Subsequently, after fixation all the samples were embedded in Tissue-
Tek III embedding wax (Sakura Finetek Europe, Zoeterwoude, 
Netherlands) and cut into 3 μm or 5 μm thick sections (in the rabbit 
samples perpendicular to the joint surface) for the histology, 
immunohistology, enhanced polarized light microscopy and Fourier-
transform infrared imaging spectroscopy. 
4.7.4 Histological stainings and analysis 
Proteoglycans were stained with cationic stains toluidine blue or safranin 
O, and bone with Masson’s trichrome staining. The possible hypertrophy 
indicating endochondral ossification of the chondrocytes was detected 
using alkaline phospatase (ALP) staining in the study III. During the 
endochondral ossification the chondrocytes become hypertrophic and 
start to secrete ALP, therefore it can be used as a marker for hypertrophic 
chondrocytes. ALP activity was demonstrated by 2 hr incubation in ALP 
substrate solution (0.2 mg/ml Naphtol AS-MX and 0.4 mg/ml Fast Red TR 
in 100 mM Tris-maleate buffer, pH 9.2) after overnight incubation with 
MgCl (1% in Tris-maleate buffer, pH 9.2) (Miao 2002). Mouse embryo and 
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bovine cartilage were used as positive and negative controls, 
respectively. 
The modified O’Driscoll score (maximum score 30) for cartilage repair 
was used to evaluate the repair quality from the safranin O stained 
sections (O'Driscoll 1988) in the rabbit study (study IV). Three observers 
scored the blinded samples independently, and the scores were averaged 
and rounded off to the nearest integer. In this histological scoring a 
variety of cellular and ECM properties were analyzed and evaluated 
using numerical values. 
 
4.7.5 Immunohistochemical staining 
Type II collagen was detected using the mouse monoclonal antibody E8 
(Holmdahl 1986) (studies II, III, IV). This antibody is directed against 
chicken type II collagen, but cross-reacts with several mammalian 
species, such as murine type II collagens (Sahlman 2004). The primary 
antibody was applied for an overnight incubation (1:500), after 1 h 
hyaluronidase treatment (Sigma, 2mg/ml in PBS, pH 5). It was detected 
using the Envision Plus kit (Dako, Glostrup, Denmark). Anti-type I 
collagen (Abcam, Cambridge, UK) was used with an overnight 
incubation (1:100) at 4°C, after 20 min in 0.1% pepsin (Sigma, St. Louis, 
MO, USA) (in 0.5M acetic acid) (study III) or 30 min in 1mg/ml pronase 
(Callbiochem, San Diego, USA) (study IV), with a subsequent 1 h 
hyaluronidase treatment at 37°C (studies III, IV). Type X collagen was 
immunostained with mouse monoclonal antibody X53 (Quartett, Berlin, 
Germany) with an overnight incubation (1:500) at 4°C (Eerola 1998) after 
pepsin and hyaluronidase treatments, as described above. For type I and 
X collagens the Envision+ System-HRP (Dako, Glostrup, Denmark) was 
used for staining. Positive and negative controls (rabbit neonatal or 
juvenile adult cartilage and bone) were used to confirm reliability of the 
tests and specificity of the antibodies, and negative controls without 
primary antibody (1% BSA in PBS) were included. 
 
4.7.6 Enhanced polarized light microscopy 
Sample sections (5 μm thick) were cut, dewaxed in xylene, and 
rehydrated as previously described (Hyttinen 2001). Tissue 
glycosaminoglycans (GAGs) were digested with bovine testicular 
hyaluronidase, type IV (Sigma, St. Louis, MO, USA) using 1000 units/ml 
in phosphate buffer for 18 hours at 37°C. The sections were left 
unstained, embedded in DPX mounting medium (Difco, East Molesey, 
UK), and examined with a computerized Leitz-Ortholux POL microscope 
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using a 5.7 μm pixel size. The degree of parallellism of the collagen 
network (as measured by the parallellism index) and the orientation 
angle of the collagen fibrils were determined (Rieppo 2008). The 
parallelism index (PI) indicates the anisotropy of the material, that is, 
whether the fibrils are running in the same direction or not. A higher PI 
(maximum value is 1) indicates that the majority of the collagen fibrils are 
running in the same direction at that given site. 
 
4.7.7 Fourier-transform infrared imaging spectroscopy 
5-μm-thick sections were prepared similarly to those used for polarized 
light microscopy (but without the digestion of GAGs), and transferred 
onto 2-mm-thick infrared-transparent ZnSe-windows. Fourier transform 
infrared imaging spectroscopy (FT-IRIS) was utilized to determine the 
amide I (1584-1720 cm-1) absorbance of the sections as a measure of 
collagen content, whereas the carbohydrate region (984-1140 cm-1) was 
used to estimate the proteoglycan content (Julkunen 2009). 
Measurements were done using a Perkin Elmer Spectrum Spotlight 300 
FTIR imaging system (Perkin Elmer, Cambridge, UK) at a 4 cm-1 spectral 
resolution and with a pixel size of 25 μm. 
 
4.8 BIOCHEMICAL ANALYSIS 
The quantitative and structural analysis for proteoglycans using 
biochemical methods was done for the constructs. After measuring the 
wet weight of the samples, they were freeze-dried, and the dry weights 
of the samples were determined.  
 
4.8.1 Quantitative analysis of proteoglycans (PGs) 
For quantitative analysis, the freeze-dried and weighted samples were 
processed with papain digestion (study III). The papain digestion 
included incubation with 1 mg/ml concentration of papain (Sigma, St. 
Louis, MO, USA) in 150 mM sodium acetate including 50 mM Cys-HCl 
(Sigma) and 5 mM EDTA (Merck KGaA, Darmstadt, Germany), pH 6.5, 
for 3 hours at 60°C to digest the PGs. Afterwards the samples were boiled 
for 10 min to inactivate the enzyme. The uronic acid contents of the 
digests were quantitated from the ethanol-precipitated samples 
(Blumenkrantz 1973). The amounts of uronic acid were normalized to the 
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wet weights of the samples to compensate for the variation in the size of 
the sample(II). 
 
4.8.2 Structural analysis of PGs 
The structural analysis was conducted using electrophoresis. The 
specimens were extracted with 4 M guanidinium HCl dissolved in (Gu-
HCl) 50 mM sodium acetate, pH 5.8, supplemented with 10 mM 
disodium EDTA (Merck), 5 mM benzaminide HCl and 100 mM 6-
aminohexanoic acid for 48 hours. For agarose gel electrophoretic analysis 
of PG subpopulations, the samples were then precipitated with 75% 
ethanol. The precipitated samples (1 μg of uronic acid) were dissolved in 
7 μl of sample buffer (1% SDS in 40 mM Tris-acetate and 1 mM sodium 
sulphate, pH 6.8), boiled for 5 min, and 7 μl of 60% sucrose and 0.05% 
bromphenol blue in sample buffer was added to each sample. The 
electrophoresis in 1.2% agarose was performed in 40 mM Tris-acetate and 
1 mM sodium sulphate, pH 6.8, for 3 hours at 60-80 mA and 40 V. After 
electrophoresis, the gel was fixed for 2 hours in methanol:acetic 
acid:water (50:7:43, v:v:v) mixture, and stained with 0.02% toluidine blue 
in 3% acetic acid for 4 hours. Excessive stain was removed by washing in 
a 3% acetic acid solution, and the gel was scanned. Similarly treated 
bovine articular cartilage (Gu-HCl and papain exracted) and chondroitin 
sulphate C (Sigma) were used as a positive control and mouse skin PGs 
(Gu-HCl extracted) as a negative control.  
 
4.9 MICRO-COMPUTED TOMOGRAPHY FOR ANALYSING 
SUBCHONDRAL BONE HEALING 
4.9.1 Micro-computed tomography (μCT) analysis (study IV) 
In order to measure and detect structural changes in the subchondral 
bone in the rabbits, the knee joint samples were scanned with a μCT 
scanner (Skyscan 1172 Skyscan, Aartselaar, Belgium). Tube voltage of 100 
kV was applied with voxel size of 15 x 15 x 15 μm3. The μCT images 
were analyzed with the CT Analyzer software version 1.9.1.0 (SkyScan). 
The 3D-analysis was performed from two separate, manually selected 
volumes of interest (VOI) for each sample. The VOI 1 (a cylinder with 4 
mm diameter and 2 mm in height) was placed within the deep part of the 
healed osteochondral lesion, while VOI 2 (a cylinder with 4 mm diameter 
and 1 mm height) was placed below the lesion. Following parameters 
were calculated for these two VOIs: bone surface- to volume ratio 
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(BS/BV), bone volume fraction (BV/TV), trabecular bone pattern factor 
(TBPf), structural model index (SMI), trabecular thickness (TbTh), 
trabecular number (TbN) and trabecular separation (TbSp). 
4.10 MECHANICAL TESTING 
The mechanical properties of samples were tested using a computer-
controlled high-resolution material testing device (Laasanen 2002) 
applying unconfined compression under displacement control (stress-
relaxation test) (study I, III), or an indentation technique under load 
control (creep test) (study IV) (Julkunen 2009). In unconfined 
compression, the sample is placed between two smooth impervious 
platens and during compression the fluid can freely flow laterally. In the 
indentation test the sample is compressed with a plane-ended indenter 
that has smaller diameter than the sample. During the stress-relaxation 
test the specimen is first subjected to constant deformation (μm), and 
then during relaxation the decrease in the stress (Pa) over time is 
recorded. The creep test is performed applying constant stress (Pa) on the 
specimen and time-dependent deformation of the sample is recorded 
(μm). To minimize the effects of proteolytic enzymes, the samples were 
balanced in a PBS bath containing protease inhibitors during the 
measurements (Rieppo 2003).  
The recorded data was then used to calculate Young's modulus at 
equilibrium, also called the equilibrium modulus (E), and dynamic 
modulus (Edyn), also known as instant modulus. The equilibrium 
modulus characterizes the properties and sfiffness of cartilage after the 
fluid flow and deformation has stopped in the tissue. The dynamic 
modulus reflects the response of the tissue to cyclic deformation (Hayes 
1972) and stiffness of the cartilage during loading. The exact details for 
measurements are explained in the original publications of the studies II, 
III and IV. 
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5 Results 
5.1 PRELIMINARY STUDIES AND BIOMATERIAL 
SELECTION 
 
In the preliminary studies rh collagens type I, II and III were tested. 
Based on the fact that type II collagen is the prominent collagen in the 
articular cartilage and on histological findings after 28 days of in vitro 
cultivations, the studies were carried on with rhCII (results presented in 
study III).  
Figure 6. Confocal microscope images after 4 weeks of in vitro cultivation of 
bovine chondrocytes in rhCII sponges (A-B) and rhCII membranes (C-D). 
Scale bar = 500 μm (A,C), scale bar 100 μm (B,D). Live cells are green, and 
dead cells red. 
 
 
Subsequently, the rhCII material was tested as a coating for cellulose 
scaffolds (Study I), as a membrane (Tiitu 2008), as a sponge (Tiitu 2008) 
and as a gel-like scaffold (also called hydrogel) (studies II, III, IV). The 
rhCII coating improved the chondrocytic phenotype preservation in the 
first study, but the cellulose material itself was not optimal as a scaffold 
material, and it was not further investigated. When chondrocytes were 
cultivated in the rhCII membranes, they  dedifferentiated and become 
fibroblast-like, could not infiltrate inside the material and populated only 
the surface of the membrane (Tiitu 2008). Therefore, the membrane could 
not provide optimal conditions for the chondrocytes in the cartilage 
repair procedure. In the rhCII sponges the phenotype of the chondrocytes 
was better preserved, cell seeding was problematic and the cells did not 
reach the inner parts of the sponges. In addition, some areas contained 
dead cells when sponges were used as a scaffold for chondrocytes. In the 
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rhCII collagen hydrogels, however, the cells were evenly distributed and 
the chondrocytes maintained their round phenotype for 4 weeks. 
Consequently, the gel-like rhCII scaffold was selected for further studies 
and modifications. 
5.2 CHONDROCYTE CULTURES IN VITRO (STUDIES I, II) 
When rhCII was used as a coating material for the cellulose sponges, the 
suitability of the rhCII material for chondrocyte cultivations was 
confirmed, as the cells in rhCII-treated sponges better maintained their 
round morphology for 3 weeks, whereas the cells in the cellulose sponges 
appeared to be flatter (Figure 6A and B). Furthermore, cell viability was 
detected to be good in the chondrocytes grown in rhCII treated sponges 
(Figure 6C).  
After these initially promising results, the remaining studies were 
focused on using rhCII-coated material as a gel-like scaffold (hydrogel). 
Cell viability remained good when the chondrocytes were cultivated in 
the rhCII gels in vitro (Figure 6D). It was noticed that the structure of the 
rhCII gels evolved during the in vitro cultivations. Initially the freshly 
fabricated rhCII hydrogels were very soft with jelly-like soft concistency 
that could be transferred by a pipette (Figure 7A). During the 4-week 
cultivation period of rhCII hydrogels and chondrocytes, the general 
appearance of the constructs changed into a clearly harder and compact 
material that could be balanced on a spatula (Figure 7B). However, the 
material was too soft for mechanical testing. Macroscopical evaluation of 
the gels showed that they also contracted during the in vitro cultivation 
period (Figures 7A and B). The contraction was most marked between 
cultivation weeks 1 and 2 and the total contraction was approximately 
47% during the 4 week long cultivation time. The cultivation method of 
using carrier plates (Figure 7A and B) to keep the hydrogels floating and 
prevent them to attach the culture dish, was proven successful.  
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Figure 6. Scanning electron microscope (SEM) images after 4 weeks of in 
vitro cultivation of bovine chondrocytes in cellulose with rhCII coating (A) 
and without coating (B). A-B scale bar = 100 μm. Confocal microscope 
images after 4 weeks of in vitro cultivation of bovine chondrocytes in 
cellulose with rhCII coating, scale bar = 500 μm (C) and in higher 
magnification showing round chondrocytes, scal bar = 100 μm (D). Live cells 
are green, and dead cells red.  
Figure 7. Compilation of findings in studies II, III and IV. Photographs from 
these studies in the first line show the gradual development of the rhCII 
constructs in the course of the studies from a soft gel consistency into firmer 
structure (A-D). In the second line, the amount of PGs showed increase 
indicated with safranin O staining (E-H). In the third line, the amount of type 
II collagen was also detected to increase as evaluated with anti-type II 
collagen staining (I-L). The tissue quality in the rabbit repair samples was 
not homogenous (H and L).  
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Histological analysis revealed that the chondrocytes were evenly 
distributed throughout the rhCII-hydrogels and the number of the cells 
increased during the culture periods of 1 day until 4 weeks (Figure 7E 
and F). The cells also started to produce ECM, which was shown as 
increased intensity of safranin O staining of the rhCII gels (Figure 7E and 
F). Type II collagen synthesis and secretion also increased during the 
cultivation period. This was indicated by the observation of a more 
intense staining of pericellular type II collagen around the chondrocytes 
(Figures 7I and J). The overall intensity of the type II collagen staining 
demonstrating increased density of type II collagen was also present. 
However it should be noted that this can partly result from the 
contraction of the gels. 
The ECM production of the chondrocytes cultivated in vitro in the 
rhCII-hydrogels was further assessed using uronic acid analysis and RT-
PCR. Since uronic acid is part of the GAG structure in the cartilage PGs, 
analysis of its content in the tissue gives an estimate of the PG content. 
The quantity of GAGs increased during the cultivation, as the amount of 
uronic acid per wet weight of the samples significantly increased from 
0.05 to 0.70 μg/mg per wet weight (p≤0.05) during the 4-week-cultivation 
period. The contraction of the gels and decrease of the water content from 
95% to 84% at 4 weeks, slightly increased the uronic acid to wet weight 
ratio. However, the increase in the total amount of uronic acid (from 1.9 ± 
1.4 μg/gel at day 1 to 7.0 ± 2.9 μg/gel at 4 weeks; mean ± SD; p=0.028) 
provided evidence for a significantly increased PG production. 
The RT-PCR analysis was used to detect changes in the ECM 
production at mRNA levels.  Relative amount of procollagen α1(II) and 
aggrecan mRNA reached its highest level after 1 week of cultivation in 
the rhCII gels in vitro. At 1 week, the relative quantity of procollagen α1(II) 
mRNA was over 12 times higher, and aggrecan mRNA levels showed 
over a seven-fold increase when compared with day 1. After the first 
week, the relative amounts of procollagen α1(I) and aggrecan mRNA had 
declined but remained above the day 1 level. 
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5.3 ANIMAL MODELS IN VIVO (STUDIES III, IV) 
To extend the experiments to larger scale living organisms, we performed 
further tests in vivo with chondrocyte-seeded rhCII-hydrogels injected 
subcutaneously in the backs of nude mice (Figure 8A), and as a repair 
material for experimentally induced osteochondral lesions in rabbits 
(Figure 9A).  
5.3.1 Macroscopic findings in nude mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Subcutaneous chondrogenesis in nude mice. Photograph A shows 
the location of injection sites of (1) rhCII-hydrogel without cells (rhCII-gel); 
(2) bovine chondrocytes in rhCII-hydrogel (rhCII-cell); and (3) bovine 
chondrocytes in growth medium (Med-cell). The subcutaneous injections 
were carried out on anesthetized mice (A). Implantation sites of rhCII-gel 
(B) and rhCII-cell (C) 6 weeks after the implantation. A closer macroscopic 
view of the rhCII-cell construct (D) and Med-cell (E) after 6 weeks. Bar = 5 
mm.  
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When the rhCII-constructs were cultivated 6 weeks subcutaneously in 
nude mouse, the macroscopic appearance of the hydrogels (Figure 7C) 
clearly changed from being soft, fragile and transparent at the beginning 
(Figure 7A). The chondrocytes within rhCII-hydrogel implants (rhCII-
cell) produced a round or oval piece of whitish, translucent and resilient 
tissue (Figures 7C, 8C and 8D). The control samples, chondrocytes in 
medium (Med-cell), also formed a piece of white tissue, but the 
appearance was thin, uneven and rough (Figure 8E). No macroscopic 
signs of vascular invasion or abnormal growth of connective tissue were 
detected around the subcutaneous constructs. Thicknesses of the tissue 
constructs were statistically different. The tissue produced by the rhCII-
cell implants was two times thicker than the Med-cell constructs (p = 
0.003). In the control samples, where rhCII-hydrogels were implanted 
without any cells, the gel structure had mostly dissolved. In this case, 
only a barely detectable thin layer of material remained at the injection 
site (Figure 8B). Therefore, these samples were not further analyzed.  
 
5.3.2 Macroscopic findings in the rabbit osteochondral repair model 
 
The macroscopical findings after using the rhCII-hydrogel with 
autologous chondrocytes in a rabbit cartilage defect model showed that 
six months postoperatively, the lesion sites were filled with repair tissue, 
that had a visibly smooth surface for the most part, but the color of the 
repair was different from the surrounding cartilage area (Figures 7D, 9A). 
The rhCII-repaired lesions showed almost 100% individual location 
filling in all animals (Figure 9A), and only one lesion out of 6 showed 
impaired filling. In contrast, the spontaneous repair was more uneven 
and contained partially filled areas and impaired filling in half of the 
animals (Figure 9B) resulting in an average of 79% filling in 
macroscopical evaluation. Some peripheral cartilage areas of the femoral 
trochleae were swollen and hyperemic (Figures 9A and 9B). This reaction 
was apparent in both repair groups and can be considered as a surgical 
response. The intact control cartilage had a smooth trochlear area (Figure 
9C). 
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Figure 9. Repair of osteochondral defects in rabbit knee joints. Photographs 
from A) intact, B) rhCII-gel repair and C) spontaneous repair in the rabbit 
femoral trochlea after 6 months of operations. The repair site is clearly 
visible at the rhCII and spontaneous repair sites. In the rhCII-repairs, the 
defects were filled with repair tissue. In the spontateous repair, the defects 
were not fully filled with repair tissue, as shown with the black arrow. Some 
of the joints were hyperemic and swollen(indicated with the white arrows). 
This reaction was present in both rhCII and spontaneous repair and was not 
caused by collagen implantation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Subcutaneous chondrogenesis in nude mice. Toluidine blue 
stainings showing extracellular matrix 6 weeks after subcutaneous injections 
of implants. The chondrocytes seeded in rhCII-hydrogels (rhCII-cell) in 
different magnifications (A, B). The chondrocytes in growth medium only 
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(Med-cell) in different magnifications (C, D). Immunostaining for type II 
collagen showed a strong signal in cell-seeded rhCII constructs (rhCII-cell), 
particularly around the chondrocytes, suggesting an accumulation of collagen 
type II (E) in these specimens. Non-cartilaginous areas, negative for type II 
collagen, were visible in collagen scaffold (hydrogel)-free constructs (Med-
cell) (F).  
5.3.3 Histological characteristics of repair tissue in vivo 
Histological analysis of the subcutaneous samples further revealed that 
the chondrocytes had formed lacunae-like structures (Figures 10 and 11). 
There were no differences in the numbers of cells contained with the 
rhCII- and Med-cells constructs. In the rabbit samples, the cellularity in 
some areas of the repair tissues was higher than in the intact tissue, 
except that the surface layer was hypocellular in both rhCII assisted and 
spontaneous repairs (Figures 12B and C). In the tissue adjacent to the 
repaired area, the cellularity was nearly normal, with mild clustering and 
slight fibrillation. Some of the repair tissues contained tiny empty spaces, 
that may have occurred due to localized cell death events (Figure 12C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Subcutaneous chondrogenesis in nude mice. Histologic stainings 
for the subcutaneous samples rhCII-cells, Med-cells and staining controls. 
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Type I collagen was mildly present in the constructs (A, B). Collagen type X 
was not detected in the constructs (D, E). Alkaline phospatase (ALP) activity 
was not detected in the constructs (G, H). Masson’s trichrome staining 
showed no bone specific staining in the constructs (J, K).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Repair of osteochondral defects in rabbit knee joints. Histological 
stains of the intact and repaired rabbit joint areas. Toluidine blue (A-C) and 
type II collagen (D-F) were detected in the intact cartilage and in the deeper 
zones if the repair tissues. Type I collagen was present in the superficial 
zones of the repaired tissue (H, I) and in the adjacent cartilage, but not in 
the intact cartilage (G). Masson’s trichrome staining (J-L) indicated the 
cartilaginous tissue.  
 
5.3.4 ECM production and quality in vivo 
The chondrogenic character and ECM production of the tissue constructs 
was examined with toluidine blue staining (Figures 10A and D, and 12D 
and F). After 6 weeks of subcutaneous cultivation in vivo, rhCII-cell 
constructs produced tissue that was heavily stained with the cationic dye 
toluidine blue (Figure 10A and C), indicating the presence of abundant 
extracellular matrix proteoglycans. The findings in subcutaneously 
cultivated Med-cells were similar, except that the constructs were more 
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condensed than the rhCII-cell construct (Figure 10B and D). Collagen 
type II immunostaining was strongly positive in both subcutaneous 
sample groups (Figure 10E and F), but the cells cultivated in medium 
were surrounded with type II-negative connective tissue (Figure 10F). 
Immunohistochemistry revealed that type I collagen was also present in 
the constructs (Figure 11A and B). To detect whether the chondrocytes 
had differentiated towards endochondral bone formation, 
immunoreactivity for type X collagen (Figure 11D and E) and alkaline 
phosphatase (ALP) was studied (Figure 11G and H). In addition, 
Masson’s trichrome (Figure 11J and K) staining was also carried out. Both 
stains for hypertrophic or mineralizing cartilage markers showed 
negative results in subcutaneous rhCII-cell, and Med-cells (Figures 11D-
E, and 11G-H). Masson’s trichrome staining indicated that the ectopic 
cartilage implants stained blue, as did normal bovine cartilage, thus 
indicating no difference from the situation in normal tissue (Figure 11J-
K). 
A more detailed analysis of ECM production was conducted using the 
uronic acid analysis and agarose gel electrophoresis for the subcutaneous 
samples. On the basis of similar uronic acid concentrations, there were no 
detectable differences in GAG content between the sample groups. 
Agarose gel electrophoretic analysis (Figure 13A) revealed that in both 
construct groups, the PGs were primarily large, exhibiting mobility 
typical for aggrecan molecules, while the amount of small PGs (relative 
mobility of approximately 0.85-0.90 in proportion to the bromphenol blue 
front) was low, consistent with previous literature (Lammi 1993, Lammi 
1994). The mobility of bovine articular cartilage proteoglycans was 
similar to rhCII-cell and Med-cell. Chondroitin sulphate C and papain-
digested cartilage had faster mobility than the small PG population 
(Figure 13A). No PG bands were seen from the mouse skin sample 
extract. 
In the rabbit cartilage repair samples, the PGs were also abundantly 
present and the appearance of the tissue was similar to cartilage in the 
deeper regions of the repaired region. However, the superficial layer had 
a low amount of PGs detected with toluidine blue (Figure 12B and C). 
Immunostaining for type II collagen clearly defined the location of 
cartilage in the normal, intact, articular cartilage (Figure 12D). In the 
repaired tissue, it was present in the deeper zone, but not in the 
hypocellular superficial layer of both repair groups (rh-CII and 
spontaneous) (Figure 12E and F). The presence of type II collagen in the 
rhCII repair tissue could be expected, since it was the major material in 
the implanted gel. However it is still possible that the implanted 
chondrocytes may have synthesized part of it, as well. However, since 
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the antibody used for immunostaining cannot distinguish the human and 
lapine type II collagen, we could not estimate the share of the collagen 
possibly synthesized by the autologous chondrocytes. In the most 
superficial layer, the hypocellular part of the repair tissue contained type 
I collagen (Figure 12H and I) in both repair groups. A thin zone of type I 
collagen was also present in the tissue adjcent to the repair area, 
indicating mild tissue deformation also occurred in the surrounding 
healthy cartilage (Figure 12H and I). In the intact cartilage, type I collagen 
was not detected, or it existed only in small , diffuse, amounts (Figure 
12G). 
 
Figure 13. Characterization of subcutaneous chondrogenesis in nude mice. A) 
Photograph of an agarose gel electrophoresis; Lane 1: rhCII-cell, lane 2: 
Med-cell, lane 3: bovine cartilage extract, lane 4: chondroitin sulphate C, 
lane 5: papain-digested cartilage proteoglycans. Toluidine blue-stained 
sections from rhCII-cell (B) and scaffold-free Med-cell (E) constructs are 
shown as a reference for FTIR-IS analysis (C and F, respectively). The 
organization of collagen network, evaluated by parallelism, was evaluated by 
polarized light microscopy of the rhCII-cell (D) and Med-cell constructs (G). 
The color scale in C and F indicates the content of collagen (blue is low and 
red high content), while the scale in D and G indicates the collagen 
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parallelism (red is low and blue high degree of parallelism). Scale bars B and 
E = 1000 μm; C and F, 2250 μm; D and G = 500 μm. 
 
The histological samples of the rabbit repair specimens were also viewed 
and analyzed using histological scoring (modified O’Driscoll method) of 
the repair tissues (O'Driscoll 1988). The scoring revealed no differences 
between the spontaneous (score 14.1 ± 2.7, n = 7) and rhCII repaired 
cartilage (score 12.5 ± 1.4, n = 6). The average score for the intact tissue (n 
= 7) was 29.1 ± 0.7, while the maximum score was 30. The average 
cartilage or average repair tissue thickness (± SD) calculated from the 
histological images was 372 ± 71 μm for the intact tissue, 411 ± 71 μm for 
the rhCII repair and 273 ± 100 μm for the spontaneous repair sections.  
The collagen and PG contents were measured using FT-IRIS. 
Surprisingly, the use of rhCII did not affect the collagen content, as they 
were similar in the subcutaneous rhCII-cells and Med-cells samples 
(Figure 13C and F). In the rhCII repairs the collagen content had higher 
variation than in the Med-cells. In the osteochondral rabbit repair 
samples, the total collagen contents were also similar between the rhCII 
and spontaneous repair, and the values were at similar levels to those in 
the intact cartilage (Figures 14A, and 15G-I). In comparison to intact 
tissue, the PG content was significantly lower in both repair groups 
(Figure 14B). In the rhCII repair group, the amount of PGs was smaller 
than in the spontaneous repair samples (Figure 14B). 
Polarized light microscopy analysis was used to evaluate the 
arrangement of collagen fibril network of the constructs. In the 
subcutaneous samples, the degree of parallelism of the collagen fibrils 
did not differ between the rhCII-cell and Med-cell samples (Figure 13D 
and G). In the rabbit repair samples, the depth-wise analysis indicated 
that, in both repair groups, the fibril orientation differed significantly 
from the intact tissue, (Figures 14D, and 15A-C)  through the whole 
depth of the  samples. The overall fibril orientation in the rhCII assisted 
repair tissue was significantly less perpendicular-to surface than in intact 
cartilage (Figures 14D, and 15A-C). The parallelism index in the rhCII 
repair was close to that in the intact cartilage (Figures 14D, and 15D-F), 
while the spontaneous repair tissue had a more inferior quality in this 
respect, showing significantly lower values in the middle and deep zones 
of the repair tissue (Figure 14C). 
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Figure 14. FT-IRIS analysis of the osteochondral repair tissue in rabbit knee 
joints. The calculated averages of parallelism index (A), the collagen fibril 
orientation in degrees (B), collagen content (C) and proteoglycan (PG) 
content (D) in the intact, spontaneous and rhCII-gel repair groups. A.U. = 
absorbance unit (amide I absorption). Mean ± Confidence interval 95%. 
Figure 15. Osteochondral repair in rabbit knee joints. Polarized light 
microscopy images demonstrating the collagen fibril orientation and 
parallellism in the intact and repair tissues as indicated above. The red color 
represents the perpedicular-to-surface and blue color the parallel-to-surface 
orientation in A-C. In D-F the red color indicates high and the blue color, low 
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anisotropy. Collagen content distribution in cartilage is shown in G-I in the 
FTIR images with red  and blue colours representing  high and  low collagen 
content, respectively.  
5.4 BIOMECHANICAL PROPERTIES OF THE RHCII-
HYDROGEL CONSTRUCTS 
Biomechanical parameters define the functional properties of the 
articular cartilage. Thus, both equilibrium and dynamic moduli of the 
tissue samples were analyzed using mechanical testing. The in vitro 
cultivation of the rhCII-hydrogels did not produce tissue hard enough to 
be measured, so they were not analyzed. Although the macroscopic 
appearance of the tissue was different between the subcutaneous rhCII-
cell and Med-cells constructs, there were no significant differences in the 
equilibrium or dynamic moduli. The mechanical stiffness did not fully 
reach that of native bovine articular cartilage (Suh 2000), but was higher 
than that obtained with in vitro cultivation of cellulose sponges. 
There were no significant differences in the values of the equilibrium 
modulus in different groups. This was despite the fact that the 
spontaneous repair tissue was somewhat softer than both the intact and 
rhCII assisted repair samples.  Similar findings were observed in the 
dynamic modulus, where the spontaneous repair tissue showed the 
lowest values (and the differences were insignificant). 
5.5 BONE HEALING IN THE OSTEOCHONDRAL REPAIR 
SAMPLES 
It appeared that the bone regeneration was good, 6 months after 
surgically induced osteochondral injury in rabbits. There were no major 
differences in the subchondral bone structure between the treatments of 
repaired cartilage, either by rhCII-assisted or spontaneous repair. The 
structure of regenerated bone was studied with μCT in two locations: in 
the vicinity of the injury (VOI1) and deeper in the bone (VOI2). A 
number of parameters extracted by the analysis software were procured. 
However, there were no major differences in most of them when 
compared with intact bone samples. In the VOI1 of the rhCII-assisted 
repair group, the trabeculae thickness (TbTh) was significantly smaller, 
and their number (TbN) higher than their respective values, obtained 
from intact tissue. However, in the VOI2, the trabeculae were thicker but 
60 
 
 
fewer than in the intact tissue, in contrast to the findings in the VOI1. In 
the spontaneous repair group, only the trabecular thickness in VOI1 
differed significantly from the intact control tissue. 
 
 
  
61 
 
 
6 Discussion 
6.1 FEASIBILITY OF  RHCII-BASED SCAFFOLDS FOR 
CARTILAGE TISSUE ENGINEERING 
6.1.1 Chondrocyte behaviour in rhCII-based scaffolds 
The use of type II collagen as a scaffold for chondrocytes in articular 
cartilage TE has been previously reported (Funayama 2008, Lee 2003, 
Nehrer 1998). Since, it is the main collagen in native articular cartilage 
ECM, type II collagen as a scaffolding material would offer a natural 
environment for the chondrocytes (Buckwalter 1999) that would, via 
integrin recognition, prevent apoptosis and phenotypic dedifferention 
(Hirsch 1997). In our studies, we observed that the use of rhCII coating 
for cellulose sponges improved phenotype preservation of the 
chondrocytes cultivated in it for 4 weeks. Without rhCII coating, the 
chondrocytes became elongated in vitro, presumably because the 
cellulose itself did not offer attachment sites for the cells and therefore 
did not favour chondrocyte growth. 
Hydrogels are widely tested for their feasibility as a scaffold for 
chondrocytes. Because cartilage is a highly hydrated tissue where 
exchange of nutrients and gases occurs mainly through diffusion, a gel-
like environment would have a higher resemblance to the natural 
composition of articular cartilage. (Drury 2003). Soft rhCII-hydrogels 
containing viable cells were achieved when they were made combining 
the rhCII in a HCl containing solution and freshly isolated chondrocytes 
in growth medium. The cells remained alive during the 4 weeks they 
were maintained in the cell cultivation conditions in vitro, demonstrating 
that the gel-like scaffold of rhCII allowed sufficient exchange of nutrients, 
oxygen and waste products. It was also evident that when the gels were 
made gently by mixing the collagen solution and the cells 
simultaneously, the chondrocytes were evenly distributed throughout 
the gel-like scaffold. A smooth cellular distribution is essential when an 
even textured tissue is desired (Risbud 2002). This has not been achieved 
often when sponges were used as a scaffold material (Mizuno 2002). The 
poor ability of the cells to migrate inside rhCII coated collagen sponges 
was also detected during this work that constitutes this thesis. The poor 
migration was possibly due to the lack of interconnected pores in the 
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collagen sponges, which prevents the movement of the chondrocytes 
deeper into the scaffolds.  
Chondrocytes are known to become elongated and fibroblast-like 
(hallmarks of de-differntiation) when grown as monolayers in culture 
(von der Mark 1977). This was also shown in our studies, when 
chondrocytes were cultivated on top of collagen membranes (Tiitu 2008). 
However, when the cells were embebbed inside 3D material, they tend to 
maintain their round phenotype and chondrocytic characteristic, chiefly, 
type II collagen and PG production (Kimura 1984). The phenotype 
preservation is probably mediated partly via collagen-integrin 
interactions. It has been reported that mechanical factors also help to 
maintain chondrocyte phenotype in cartilage TE constructs, as shown in 
non-collagenous gel-like environments, such as agarose (Kolettas 1995), 
when combined with or without mechanical loading (Bian 2010).  
6.1.2 ECM production in rhCII cultivated chondrocytes 
When we cultivated chondrocytes inside the rhCII-hydrogels, we clearly 
detected cartilaginous formation in vitro and in vivo, and the 
chondrocytes produced cartilaginous ECM molecules, type II collagen 
and PGs, as demonstrated with RT-PCR, histology and biochemical 
analyses. During in vitro cultivation the amount of PGs increased. 
However, even after 4 weeks, the amount of PGs in the ECM of the 
tissue-engineered constructs was only 7% of the levels in the normal 
articular cartilage. The amount of PGs in the osteochondral rabbit repair 
tissue that received  rhCII-coated implants was also lower than in the 
intact cartilage, but to a lesser extent. The values for PG content were 65% 
of that obtained from intact articular cartilage, demonstrating that 
intensive PG production had taken place during the 6-month-recovery 
period. The amount of collagen in the rhCII assisted osteochondral 
repairs in the rabbits was also lower compared to intact cartilage, but at 
an insignificant level. Since it is difficult to differentiate between 
collagens of different species reliably, and because we did not use any 
predefined markers in the rhCII collagen, we can confirm neither how 
much of the type II collagen was produced by the implanted 
chondrocytes, nor how much of it was of rhCII origin. However, RT-PCR 
performed on the in vitro samples revealed increased mRNA levels for 
type II procollagen, and  histology for type II collagen showed increased 
pericellular staining, indicating active type II collagen synthesis. 
Therefore, it is reasonable to assume that some of the type II collagen 
detected in the rhCII-repaired tissue was produced by the implanted 
lapine chondrocytes, although part of it could originate from the 
implanted rhCII itself.  
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 6.1.3 Water content and contraction in rhCII-hydrogels 
In normal articular cartilage, the water content of the tissue is estimated 
to be 65-80% (Newman 1998). In the rhCII-hydrogels, combined with 
chondrocytes, the water content was first 95%, but during the in vitro 
cultivation for 4 weeks, this concentration decreased to 84%, 
consequently approaching the water composition in the normal articular 
cartilage. When the rhCII-hydrogels combined with chondrocytes were 
cultivated for 6 weeks subcutaneously in nude mice, the water content of 
the tissue constructs was 82%. This result implies that the water loss is 
greatest during the first 4 weeks and the water content in the in vivo 
cultivated samples remains at the same levels as that found in intact 
cartilage. Since, in the native articular cartilage, PGs are responsible for 
water retention (Mow 1999), their elevated amounts, produced by the 
implanted chondrocytes, presumably affects water content in tissue-
engineered constructs, helping it reach levels similar to those described 
for normal articular cartilage.  
Decreasing water content during cultivation also leads to the 
contraction of the gels. The diminished size of collagen gels over time, 
has been reported previously (Galois 2006). Experiments with fibroblasts 
have shown that this process is affected by many factors. This includes, 
but is not limited, to collagen concentration, cell density, and growth 
factors (such as transforming growth factor-β and platelet derived 
growth factors) (Chen 2006, Malemud 1994). In both our in vitro and in 
vivo studies, we noticed that when rhCII-hydrogels were cultivated 
without cells, they dissolved during cultivation. However, in a previous 
study by Hunter and coworkers, it was noticed that when the type I 
collagen gels were cultivated without cells, the gels did not dissolve nor 
contract, in contrast to the contraction of 37% when bovine chondrocytes 
were present in the gels (Hunter 2002), indicating that the contraction is 
somehow related to cellular interactions. The reasons and consequences 
of the contraction are not fully understood, but obviously when even 
filling of the defect is desired, a large-scale contraction is an unwanted 
result. Contraction in a cartilage repair could be avoided using 
precultivated constructs where the major size reduction has already 
occurred (Kawamura 1998). Alternatively, specific treatments that inhibit 
the contraction, such as dihydrocytochalasin B (Galois 2006), or 
photochemical cross-linking could be used (Ibusuki 2007). However this 
could have the effect of inhibiting the elimination of excessive tissue. 
Excess tissue may interfere with proper functioning of the cartilage and 
joint. 
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6.1.4 Maintenance of the hyaline cartilage phenotype 
All the TE methods that use isolated chondrocytes or differentiated MSCs 
rely on the finding that the detached cells are capable of proliferation, 
growth, and ECM production (Brittberg 1996), although when existing 
inside the ECM in their innate surrounding, the mature chondrocytes 
rarely express these functions (Buckwalter 1998b). Consequently, it can 
be speculated that the proliferation and growth detected in the isolated 
and cultivated chondrocytes are features of a process that resembles the 
earlier developmental stages of cartilage. Accordingly, there is a 
possibility that when growth and proliferation is initiated in mature 
chondrocytes, this process can lead to chondrocyte hypertrophy and 
ossification (Dell'Accio 2001), those actions that take place during the 
normal development in transient cartilage (Goldring 2006). In our studies 
using the nude mice and subcutaneous cultivation of rhCII and 
chondrocytes, we tested our specimens using different markers for 
hypertrophic chondrocytes and bone. We did not notice signs of 
hypertrophy or ossification when using the alkaline phosphatase activity, 
type X collagen expression and Masson’s trichrome staining as markers 
in our subcutaneous samples of rhCII and chondrocytes.  
In addition, no signs of vascular formation, inside the subcutaneous 
constructs, were detected. Nevertheless, it was evident that the 
implanted chondrocytes inside the rhCII gels were able to acquire 
sufficient nutrients and oxygen from the surrounding subcutaneous 
fibrous tissue because of the constructs showed growth and maturation. 
In native articular cartilage chondrocytes obtain the essential 
supplements from the synovial fluid via diffusion (O'Hara 1990), and in 
the subcutaneous environment, the extracellular fluid must have served 
this purpose.  
6.2 CLINICAL IMPLICATIONS 
6.2.1 RhCII-hydrogels improved filling in cartilage lesions 
If the transplanted chondrocytes alone are capable of tissue formation 
after ACT procedure (Brittberg 1994), it is highly probable that the repair 
procedure would benefit from embedding the cells inside a biomaterial, 
where the filling of the lesion site and chondrocyte distribution would be 
enhanced (Figure 16). This is the main hypothesis behind all TE 
techniques using biomaterials. In the course of the studies of this thesis, it 
was noticed that the subcutaneously cultivated constructs in nude mice 
were more even when rhCII was used as a scaffold for chondrocytes in 
comparison to cells without any scaffolding material. Accordingly, in the 
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osteochondral repair study in the rabbits, the rhCII-hydrogel assisted 
repaired lesions showed more even filling than the spontaneous repair 
when they were macroscopically evaluated, 6 months post-operatively. 
In the rhCII assisted repaired tissue, only 1 lesion of 6 showed impaired 
filling. The average filling in the repaired osteochondral defects in rabbits 
that received rhCII-hydrogel implants with autologous chondrocytes was 
99%. In comparison, spontaneous repair samples showed impaired filling 
in half of the animals, resulting an average of 79% filling in 
macroscopical evaluation. Comparable results (88 ± 6% filling) were 
obtained in a study where autologous chondrocytes and type II collagen 
scaffold (sponge) were used to repair canine chondral defects (Lee 2003).  
 
Figure 16. Schematic presentation of cartilage injury (chondral), and repair 
of cartilage injury using autolologous chondrocyte transplantation (ACT), and 
rhCII gel combined with chondrocytes.  
 
 
6.2.2 Quality of the rhCII repair tissue and fibrillation 
Although the filling was better in the repaired osteochondral lesions in 
the rabbits, which received rhCII-hydrogel implants, the quality of the 
new tissue was not totally satisfactory. Whilst, the deeper regions of the 
rhCII repaired cartilage contained type II collagen and PGs, the 
superficial layer lacked these components and resembled fibrous tissue in 
that it was observed to contain type I collagen immunoreactivity and 
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hypocellular regions. Fibrillation of the superficial layer is a persistent 
problem in cartilage repair (Minas 2011). The reasons behind this 
phenomenon are still largely under speculation and, therefore, when 
fibrillation occurs, it remains incurable at the moment. Superficial 
fibrillation might be a consequence of the gradual regression of immature 
repair tissue and chondrocytes (that had initially attempted to produce 
hyalinous ECM). On the other hand, it might have been due to an 
immediate loss of or a weakening in the chondrocytes ability to produce 
ECM. In this case, the chondrocytes are unable to produce normal 
hyaline ECM after injury, and instead fibrous tissue is generated. 
The injured cartilage becomes more vulnerable to degeneration and 
development of posttraumatic osteoarthritis (Brown 2006). The 
degradative enzymes (Kurz 2005, Tchetverikov 2005) and cytokines, such 
as interleukin 1 and TNF-α (Goldring 2000) secreted by chondrocytes 
after injury, affect the whole joint. It has been shown that immature tissue 
in younger animals, is even more vulnerable to matrix destruction after 
cartilage injury (Kurz 2004, Levin 2005). In the case of cartilage 
regeneration after injury, the newly synthetized repair tissue is also 
immature, and more sensitive to mechanical loading. It is possible that 
the collagen structure of the immature repair tissue becomes more easily 
damaged, leading directly to loss of PGs or a progressive inability to hold 
them inside the tissue. The loss of PGs is also affected by several 
degradative enzymes, produced by the chondrocytes after injury (Kurz 
2005). In our osteochondral rhCII assisted repair samples, the collagen 
content was lower only in the superficial layer (overall collagen contents 
were not statistically different from intact specimens), but the amounts of 
PGs were significantly lower throughout the repair tissue thickness. We 
did not use any enhancing substances in our studies to prevent the loss of 
neither PGs nor GAGs, or stimulate their production. The use of enzyme 
inhibitors such as the MMP inhibitor, CGS 27023A (DiMicco 2004),  
caspase inhibitors (D'Lima 2001b) or antioxidative substances (Del Carlo 
2002) to inhibit chondrocyte apoptosis, have been shown to decreaseGAG 
loss or chondrocyte cell death after injury.  
After injurious compression in vitro, the expression of type I collagen 
has been detected to increase by 2.5-fold in 24 hours (Lee 2005). In our 
rabbit osteochondral repairs, a layer of type I collagen was detected in the 
most superficial layer of the rhCII-assistedand spontaneously repaired 
tissue. It may be that after articular cartilage damage, the repair program 
in the remaining chondrocytes activates and results in an attempt to 
build up fibrous “scar-like” repair tissue into the lesion site and this 
ultimately leads to the infamous poor quality of the spontaneous repair 
tissue. Nevertheless, the use of adult (dissected from cartilage biopsy and 
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enzymically isolated) chondrocytes as a cell source for cartilage TE is 
propably not the best option, allthought they are currently widely used. 
In addition to the harsh digestion protocols, monolayer expansion of the 
adult chondrocytes causes dedifferentiation that will generate ageing in 
the chondrocytes and compromise the normal phenotype and function 
(Khan 2008). The fact that we used monolayer cultivated adult 
chondrocytes in our rabbit experiment might have affected the slightly 
fibrillated outcome in the rhCII repaired cartilage tissue. However, 
because the spontaneous repair tissue was equally fibrillated, the initial 
condition of the transplanted cells is not the only problem. In 
spontaneously repaired tissue, the cells responsible for the growth of new 
tissue (MSCs, progenitor cells, migrating chondrocytes) are affected by 
the aforementioned cytokines as well as other mediators that are present 
in the injured joint. Similar conditions affect the transplanted 
chondrocytes, if no measures to prevent the actions of these extrinsic 
agents are taken.  
In our osteochondral repair study we noticed that a thin layer of type I 
collagen was covering also the adjacent tissue of the repaired cartilage 
(both in spontaneous and rhCII assisted repair tissues). In the previous 
literature the occurrence of type I collagen after articular cartilage injury 
has been rarely reported, even in the control specimes of spontaneous 
repairs. The production of type I collagen is strongly associated with OA 
(Gebhard 2003, Martin 2001). Its expression has been shown to be 
elevated after mechanical injury in vitro as well (Lee 2005). The finding of 
type I collagen in the adjacent tissue surrounding a cartilage lesion 
therefore implies that the injury is causing extended changes also to the 
surrounding tissue and not only in the lesion area. At the macroscopic 
level, the joints of the rabbits appeared to be partly swollen and 
hyperemic at the time of sample preparation, 6 months post-operatively. 
This phenomenon took place in both the spontaneous and rhCII-induced 
repair groups. This implies that the rhCII material did not cause collagen-
specific inflammation. At this moment, it is unclear, whether the swelling 
and incidence of type I collagen indicate the early development of post-
traumatic OA, or do they represent normal reversible changes in the 
joints after trauma. 
The problems relating to transplantation of adult chondrocytes in 
cartilage repair procedures might be overcome in the future with the use 
of MSCs or chondrogenic progenitor cells, with combination of suitable 
growth factors (Gerter 2012). In addition, the use of specific anti-
inflammatory agents, in combination with cell transplantation, could 
hinder the fibrillation and degradation of the repaired cartilage. 
Additionally, the use of artificial surface layer, such as collagen 
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membrane, to cover the repaired area, could diminish superficial 
fibrillation. No periosteal flap on top of the gel repair constructs was 
used in the rabbit study. This is because of the reported tendency to 
overgrowth when periosteum has been used (Recht 2003) and the 
difficulties in operating such small scale surgery in rabbit joints.  
6.2.3 Collagen degradation and immunogenicity 
The degradation of rhCII containing material, which was not separately 
studied in the thesis, has also an effect to the composition of the repair 
structure. Studies related to collagen fillers in soft tissue augmentation 
showed that the life time for these fillers, under patients’s skin, was from 
3 to 18 months (Baumann 2006). In our nude mouse study, where plain 
rhCII-hydrogel was injected subcutaneously, a thin layer of material was 
observed at the injection site after 6 weeks, and most of the initial gel 
volume was dissolved at that time. The increase in the MMP 13 
expression of chondrocytes cultivated in the collagen (type I and III) 
containing gels shows that the chondrocytes initiate collagen degradation 
when embedded inside gels (Galois 2006). Generally it is assumed that 
the initially implanted collagen biomaterial is degraded in the course of 
time (Drury 2003), although this has not been demonstrated taking place 
for chondrocytes or cartilage tissue.  
The supposedly higher immunogenicity of type II collagen has raised 
concerns, since it may induce arthritis when injected into mice or rats 
(Brand 2007), and antibodies to type II collagen are present in the 
rheumatoid arthritis in human patients (Cremer 1998). However, the 
relationship between the type II collagen and autoimmunity response is 
not straightforward as the induction of the disease in animal models 
requires use of an adjuvant that promotes the inflammatory reaction 
(Brand 2007) and the connection between the cause and result is unclear. 
Secondly, there is no evidence that induced autoimmunity in humans 
could result from type II collagen implantation, as no such data exists 
(Lynn 2004).  Finally, type II collagen gel in rabbits (Funayama 2008) and 
type II collagen scaffolds in dogs (Lee 2003, Nehrer 1998) do not cause 
detectable immunological reactions, as well. 
 
6.2.4 Integration of repair tissue 
The integration of the rhCII assisted osteochondral repair tissue in the 
rabbits into the subchondral bone was judged to be good. However, 
lateral integration into the adjacent cartilage was incomplete. Earlier data 
have demonstrated that the integration of the repair tissue with the 
adjacent healthy cartilage is problematic (Khan 2008, Shapiro 1993). 
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Several factors are known to inhibit or weaken the integration of a repair 
transplant: excessive degradative processes taking place in cartilage and 
surrounding tissues, and the anti-adhesive properties of PGs and other 
molecules, such as lubricin, in the synovial fluid (Englert 2005, Schaefer 
2004). The border area surrounding the defect almost inevitably contains 
dead cells, surrounded by extensive ECM, which could, at least partially, 
be removed by degrading enzymes, such as chondroitinase (Hunziker 
1998) to enhance chondrocyte mobility and improve the integration of the 
immature constructs into the host cartilage. In summary, it is possible 
that some part of the disintegration detected in the rabbit study in the 
osteochondral repair samples was an artefact due to the tissue processing 
protocol for histology.  
 
6.2.5 Collagen fibril organization and mechanical properties 
Collagen fibril organization is subjected to alterations during growth 
and maturation (Julkunen 2010). In mature, intact cartilage, collagen 
fibrils assembly and form arch-like structures. Of course, the collagen 
fibrils are randomly organized in the freshly manufactured gels, such as 
rhCII-hydrogels with chondrocytes. The knowledge about how collagen 
fibrils organize and form large orientated structures during the normal 
development and maturation or during the repair process is largely 
unkown, currently. For that reason, there are no specific treatments to 
improve the organization of the collagen fibrils, but instead it is only 
anticipated that the correct arrangement would be achieved after 
transplantation of TE construct or biomaterial. The overall fibril 
orientation in the rhCII assisted osteochondral repair tissue, post-
operatively in the rabbits, was significantly less perpendicular, with 
respect to the surface, than in the intact cartilage. This shows that the 
collagen fibrils were still more randomly distributed than in intact 
cartilage after 6 months. In the spontaneous repair model, the average 
fibril orientation was not statistically different from the intact tissue, 
indicating that newly synthesized collagen fibrils were in an orientation 
that closely resembled normal tissue, when no scaffolding matrix was 
used. When the parallelism index, which evaluates whether the fibrils 
run in the same direction or not, was evaluated, the rhCII showed more 
similarity with the intact tissue than the spontaneous repair. In the 
spontaneously repaired tissue samples, the parallelism index was 
significantly lower than in the intact cartilage, especially in the middle 
and deep zones. The random organization of collagen fibrils resembles 
the earlier development stages of cartilage, rather than the mature tissue 
where distinct zonal organization is predominant (Julkunen 2010). It is an 
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open question whether the maturation process of collagen fibrils can take 
place distinctively inside the repair tissue in the adult cartilage leaving 
the intact tissue untouched in the cases of injured cartilage. It is also not 
clear how the process of degradation of the implanted scaffolding 
material alongside ECM production and modification would function in 
reality. Although the collagen fibril organization and properties are an 
important factor of intact cartilage, they are seldom evaluated in the 
repair studies, and no such data exists from human patients, to our 
knowledge.  
Even though the structural characteristics of collagen fibrils and ECM 
differed from the intact cartilage in the repairs of rabbit osteochondral 
injuries, the mechanical properties of the rhCII assisted repaired cartilage 
were not statistically different from the intact cartilage in terms of 
equilibrium and dynamic moduli. The rhCII assisted repaired cartilage 
had slightly improved mechanical properties than the spontaneously 
repaired cartilage (the difference was insignificant). Usually there is 
correlation between the quality and mechanical properties of the cartilage 
(Julkunen 2009). However in our results, the inferior quality of the rhCII 
assisted repaired cartilage tissue (especially in the superficial layer), as 
measured in histology, did not result in any significant worsening of the 
mechanical function of the repaired tissue. This might be partly 
explained by the different orientation of collagen fibrils, in the repaired 
cartilage that received rhCII-hydrogel implants that might cause 
stiffening of the tissue. Another explanation might be the challenges 
faced during the measuring protocol. The mechanical testing we used to 
analyze dynamic and elastic properties of the samples requires 
positioning of preset load onto the cartilage, prior to the indentation 
protocol. The surface irregularities and softness of the repair tissue in the 
injured cartilage complicated the accomplishment of this task and 
resulted in a flattening of the superficial tissue before the measurements 
took place. Due to this, the mechanical results of the repair tissue 
possibly represent the mechanical properties of the deeper areas of repair 
tissue that contained also histologically good-quality tissue, and 
excluding the fibrillated superficial layer. 
 
6.2.6 Translational results and the source of collagen 
It is known that an animal model with repair characteristic similar to the 
human species does not exist (Minas 2011), and the animal experiments 
that are used by others and in this thesis project, offer only translational 
results. In subcutaneous rhCII assisted cultivation in the mice the 
constructs showed smooth surfaces, a result which might predict also 
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improved surface properties in cartilage repair. However, despite the 
initially promising results, the surfaces of osteochondral defects in the 
rabbit joints became microscopically fibrillated and the repair outcome 
was not much improved compared to the results of spontaneous repair 
when the rhCII was implanted. This could be partly explained to be due 
to species specific differences. It ha sbeen shown that rabbit cartilage 
differs from human in terms of thickness, resident cell population density 
and repair capacity (Minas 2011). For example, in rabbits spontaneous 
cartilage repair is generally good when compared to that observed in 
human patients. Therefore, it is difficult to estimate the exact beneficial 
effect the rhCII-hydrogel could provide in humans for cartilage 
regeneration as a scaffold biomaterial. It is also possible that the full 
benefit of using human type II collagen is not utilized in the animal 
models due to inter species differences.  
If collagen is used as a scaffold for chondrocytes in articular cartilage 
reconstruction for patients, hypothetically the best option would be to 
use collagen of a human type. The collagens that are currently used for 
cartilage TE are of animal origin, and therefore raise questions about 
safety (Lynn 2004), for example the use of bovine collagens poses a 
possible risk to exposure to cattle derived diseases such as bovine 
spongiform encephalopathy (Matarasso 2006). The risk of contagious 
disease is evident also with human derived biomaterials. The type I and 
III collagens have been extracted from cadavers or from fibroblast 
cultivations and used as skin fillers. It is not known if these were 
properly screened for human pathogens capable of horizontal transfer. 
The material itself may be hazardous, due to adverse reactions in 
heterologous humans. These human derived collagens have been 
reported to cause only mild adverse reactions, such as bruising. 
(Baumann 2006). Besides cadaver-originated collagens, it is otherwise 
difficult to obtain human type II collagens, except using recombinant 
collagens. Therefore, rhII collagen could offer a safe and reliable source 
as a filler material to be used in clinical operations, such as articular 
cartilage TE, instead of the currently used animal collagens.  
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7 Summary and conclusions 
The results in the present study evaluated the feasibility of rhCII as a 
scaffold for articular cartilage repair. Various experimental methods were 
utilized to assess suitable formulations for the delivery of rhCII to 
cartilage damage. Its suitability was measured in terms of cellular, ECM 
and biomechanical properties. The main findings and conclusions can be 
summarized as follows: 
 
1. When chondrocytes were grown in rhCII-based material, they 
were viable and able to produce articular cartilage specific ECM: 
mainly type II collagen and PGs. 
2. The optimal formula for rhCII was a gel-like scaffold, which 
allowed for an even cell distribution and growth as well as ECM 
production. The gel-like scaffolding material of type II collagen 
could be further improved by combining with other ECM 
molecules or growth factors in the future studies. 
3. The use of rhCII as a gel-like scaffold for chondrocytes in 
osteochondral repairs improved the filling of the lesions and 
resulted in slightly improved mechanical properties in comparison 
to spontaneous repair. However, the use of rhCII in the 
osteochondral repair procedure did not solve the problems of 
incomplete integration of the repair tissue into adjacent cartilage 
and fibrillation in the superficial repair cartilage.  
4. Therefore, before the rhCII can be used on human patients, further 
studies concerning enhancing the integration and surface 
properties of the repair tissue are needed. 
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Articular cartilage injuries require 
surgical intervention in order to re-
generate repair tissue. In this thesis, 
tissue engineering of cartilage was 
studied using a novel biomaterial of 
recombinant human type II collagen 
(rhCII) as a scaffold for chondrocytes. 
This work confirmed the feasibility of 
rhCII to be used for cartilage tissue 
engineering. When osteochondral de-
fects were repaired with rhCII, slight 
improvement was detected in the 
filling of the lesions and in mechani-
cal properties of the repair tissue in 
comparison to spontaneous healing. 
These results also emphasize the 
complex nature of cartilage repair and 
the importance for further studies.
